2012 CRS Annual Meeting Abstracts

 

The CRS Annual Meeting & Exposition offers over 750 podium and poster presentations. Below you will find podium presentation within scientific sessions and mini symposia grouped by day followed by the poster categories. Click on a session to be brought to the presentations, from there you may access the abstracts if you are logged in and are registered to attend the annual meeting. Abstracts will also be available to current members after the meeting concludes.

Search Abstracts

Shortcuts to Podium Sessions

Monday
Bioactive Materials/C&DP: Imaging Diagnostics for Material Characterization
Bioactive Materials: Biomaterials
C&DP: Fragrances and Flavors
Mini Symposia: Active Targeting vs. Passive Targeting
Veterinary: Protein and Peptide Therapeutics for Animal Patients
Bioactive Materials/Veterinary: Protein and Vaccine Delivery
Bioactive Materials: Nanomedicines
Bioactive Materials: Oral Controlled Release
C&DP: Hydrogel Delivery Systems in Consumer Products
Mini Symposia: Recombinant Polymers - Macromolecules from Microbes

Tuesday
Bioactive Materials: DNA and RNAi Delivery
Bioactive Materials: Drug Delivery to the Brain
Bioactive Materials: Intracellular Processes
C&DP: Consumer and Industrial Applications of Nanoparticle Technology
Mini Symposia: Morphologies and Cell Responses
Bioactive Materials: Inorganic Nanosystems
Bioactive Materials: Oncology and Tumor Targeting
Bioactive Materials: Transdermal Drug Delivery
C&DP: Nutraceuticals and Functional Foods
Mini Symposia: Smart Textiles

Wednesday
Bioactive Materials/C&DP: Nanofibers/Nanoparticles
Bioactive Materials: Stem Cell and Regenerative Medicines
Bioactive Materials: Theranostics and Cancer Nanotechnologies
Bioactive Materials: Translational Nanomedicine
Mini Symposia: New Chemistries - Click It, Fit It, Test It

Shortcuts to Poster Sessions

Imaging Diagnostics for Material Characterization
Biomaterials
DNA and RNAi Delivery
Drug Delivery to the Brain
Inorganic Nanosystems
Intracellular Processes
Nanomedicines
Oncology and Tumor Targeting
Oral Controlled Release
Stem Cell and Regenerative Medicines
Theranostics and Cancer Nanotechnologies
Transdermal Drug Delivery
Translational Nanomedicine
Consumer and Industrial Applications of Nanoparticle Technology
Hydrogel Delivery Systems in Consumer Products
Nutraceuticals and Functional Foods
Protein and Vaccine Delivery

PODIUM PRESENTATIONS

Bioactive Materials/C&DP: Imaging Diagnostics for Material Characterization     [RETURN TO TOP]

1  Invited Speaker: Imaging Techniques for the Characterisation of Advanced Delivery Systems and Biomedical Systems. Presenter: Martyn Davies, University of Nottingham, UNITED KINGDOM. Author(s): M. Davies. VIEW ABSTRACT

3  Confocal Raman microscopy as a novel approach for development and chemically resolved characterization of a drug permeation model. Presenter: Birthe Kann, Department of Biopharmazie and Pharmaceutical Technology, Saarland University, GERMANY. Author(s): B. Kann, S. Gantzsch, U. F. Schaefer, C. Lehr, M. Windbergs. VIEW ABSTRACT

4  The Studies of Newly Synthesized Polymer-Coated SPION in Sprague-Dawley Rats. Presenter: Sung-Joo Hwang, Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Republic of Korea, KOREA. Author(s): S. Hwang, J. Ahn, H. Kang, J. Park, W. Cho, B. Sun. VIEW ABSTRACT

5  An Electrospun Triple-Layered PCL-PEVA-PCL Nanofibre Matrix Controlled Release Drug Delivery System. Presenter: Ian Blagbrough, University of Bath, UNITED KINGDOM. Author(s): N. Alhusein, P. De Bank, I. S. Blagbrough. VIEW ABSTRACT

Bioactive Materials: Biomaterials     [RETURN TO TOP]

6  Invited Speaker: Self-assembled polysaccharide nanogels with chaperon function for protein delivery. Presenter: Kazunari Akiyoshi, Kyoto University, JAPAN. Author(s): K. Akiyoshi. VIEW ABSTRACT

7  Curcumin-loaded triblock poly (2-methyl-2-oxazoline-b-tátrahydrofurane-b-2-methyl-2-oxazoline) copolymer restores a functional ΔF508-CFTR in the plasma membrane of ΔF508-CFTR cells.. Presenter: Patrick Midoux, CNRS UPR4301, FRANCE. Author(s): P. Midoux, C. Gonçalves, J. Gomez, B. Rasolonjatovo, T. Le Gal, T. Montier, P. Lehn, C. Pichon, P. Guágan, H. Cheradame. VIEW ABSTRACT

8  Control of Transcription Factors by Redox Nanoparticle for Novel Antitumor Nanotherapy. Presenter: Yukio Nagasaki, Department of Materials Science, Graduate School of Pure and Applied Sciences, University of Tsukuba, JAPAN. Author(s): Y. Nagasaki, Y. Ozaki, T. Yoshitomi. VIEW ABSTRACT

9  A guanidine-substituted polyamidoamine with outstanding antiviral activity against Herpes Simplex Virus, Papilloma Virus, Cytomegalovirus and probably other DNA viruses. Presenter: Paolo Ferruti, Dipartimento di Chimica Organica e Industriale - Università di Milano, ITALY. Author(s): P. Ferruti, D. Lembo, M. Donalisio, E. Ranucci, A. Manfredi, R. Cavalli. VIEW ABSTRACT

C&DP: Fragrances and Flavors     [RETURN TO TOP]

11  Invited Speaker: Encapsulation of fragrances - an overview. Presenter: Laurence Lee, Vision Processing Technologies LLC. Author(s): B Patel. VIEW ABSTRACT

12  Micromanipulation and Finite Element Analysis to Determine the Mechanical Strength of Perfume Microcapsules. Presenter: Zhibing Zhang, University of Birmingham, UNITED KINGDOM. Author(s): R. Mercadá-Prieto, R. Allen, Z. Zhang. VIEW ABSTRACT

13  Niosome as a carrier for oral delivery of Ginkgo biloba Extract. Presenter: Jingyuan Wen, School of Pharmacy, University of Auckland, NEW ZEALAND. Author(s): Y. Jin, L. Teng, W. Zhang, D. Liu, J. Wen. VIEW ABSTRACT

14  Thermoplastic Shaping for Pharmaceuticals: Coupling Hot Melt Extrusion with Injection Moulding. Presenter: Bernd Liepold, Abbott GmbH & Co KG , GERMANY. Author(s): B. H. Liepold, M. Pauli. VIEW ABSTRACT

15  Compritol® 888 ATO Lipid Matrices for Sustained Release Processed by Hot-Melt Extrusion. Presenter: Dennis Douroumis, University of Greenwich, School of Science, UNITED KINGDOM. Author(s): D. Douroumis, M. Maniruzzaman, K. Vithani, S. Mostafa, Y. Cuppok. VIEW ABSTRACT

Mini Symposia: Active Targeting vs. Passive Targeting     [RETURN TO TOP]

16  Invited Speaker: Active vs Passive Targeting of Drug Delivery Systems: Opportunities and Pitfalls. Presenter: Theresa Allen, University of Alberta, CANADA. Author(s): T. M. Allen. VIEW ABSTRACT

17  Invited Speaker: Design and Biorecognition of Water-Soluble Macromolecular Therapeutics. Presenter: Jindrich Kopecek, University of Utah, U.S.A.. Author(s): J. Kopecek, J. Yang. VIEW ABSTRACT

18  Invited Speaker: Ligand-directed therapy and molecular imaging based on invivo phage display technology. Presenter: Renata Pasqualini, The University of Texas MD Anderson Cancer Center, U.S.A.. Author(s): R. Pasqualini, W. Arap. VIEW ABSTRACT

19  Invited Speaker: Drug Targeting to Tumors: To Actively Target, or Not to Actively Target? Presenter: Gert Storm, University of Utrecht, NETHERLANDS. Author(s): G. Storm, T. Lammers, R. Schiffelers. VIEW ABSTRACT

Veterinary: Protein and Peptide Therapeutics for Animal Patients     [RETURN TO TOP]

20  Invited Speaker: A Spoonful of Lipid Helps the Medicine go Down. LiporaleTm- an Oral Delivery System for Mucosal Vaccination. Presenter: Frank Aldwell, Immune Solutions Ltd, NEW ZEALAND. Author(s): F. E. Aldwell. VIEW ABSTRACT

21  Polymeric nanoparticles for delivery of therapeutic compounds to wild animals. Presenter: Arlene McDowell, University of Otago, NEW ZEALAND. Author(s): A. McDowell, A. P. Kafka, J. Z. Chiu, B. J. McLeod, T. Rades. VIEW ABSTRACT

22  Evaluating the Role of Dosage Size and Feeding on Gastric Retention in the Dog. Presenter: Emma McConnell, MSD, UNITED KINGDOM. Author(s): E. L. McConnell, A. Lalloo, L. Jin, R. Elkes, H. Wu. VIEW ABSTRACT

23  Quantitation of sustained release of triptorelin in beagle dog plasma by liquid chromatography-tandem mass spectrometry. Presenter: Wanhui Liu, School of Pharmacy, Yantai University, PRC PEOPLES REP OF CHINA. Author(s): W. Liu. VIEW ABSTRACT

Bioactive Materials/Veterinary: Protein and Vaccine Delivery     [RETURN TO TOP]

24  Invited Speaker: Uniform PLGA Microspheres Sustain NSAID Blood Levels With Zero-Order Kinetics. Presenter: Cory Berkland, University of Kansas and Orbis Biosciences, U.S.A.. Author(s): Q. Shang, X. Wang, D. W. Dumbauld, M. Singh, M. Apley, B. Kukanich, C. Berkland. VIEW ABSTRACT

25  Engineered Pathogen-like Particle Subunit Vaccines Induce Robust, TH1-Biased Immunity. Presenter: Joseph Rosenthal, Cornell University, U.S.A.. Author(s): J. Rosenthal, C. Huang, A. Doody, M. DeLisa, S. Mendez, D. Putnam. VIEW ABSTRACT

26  PTHrP to Prevent Curve Progression in a Novel Murine Model of Early Onset Scoliosis. Presenter: Michael Sullivan, McGill University Department of Surgery, Research Institute of the McGill University Health Centre, CANADA. Author(s): M. B. Sullivan, A. Esmaeel, M. Kneifel, J. A. Ouellet, N. Saran, J. E. Henderson. VIEW ABSTRACT

27  CapsInjectTM: LBL Coating Technology for Controlled Deliveryof Biologicals. Presenter: Michaela Grabo, Ms. , GERMANY. Author(s): O. Sakr, M. Grabo, L. Cuellar, G. Borchard. VIEW ABSTRACT

28  Optimising transcutaneous immunization using microneedles and a colloidal carrier. Presenter: Sarah Hook, School of Pharmacy, University of Otago, Dunedin, NEW ZEALAND. Author(s): T. Rattanapak, J. Birchall, I. Meglinski, T. Rades, S. Hook. VIEW ABSTRACT

Bioactive Materials: Nanomedicines     [RETURN TO TOP]

29  Invited Speaker: Nanomedicines for Hyperactive Glia. Presenter: Dusica Maysinger, McGill University, CANADA. Author(s): D. Maysinger, A. R. McKinney. VIEW ABSTRACT

30  Induction and Targeting of the Heat Shock Response in Prostate Cancer. Presenter: Nate Larson, University of Utah, U.S.A.. Author(s): N. Larson, A. J. Gormley, S. Sadekar, R. Robinson, A. Ray, H. Ghandehari. VIEW ABSTRACT

31  NanostructuredThin Film Devices for Delivery of Protein Therapeutics to the Eye. Presenter: Daniel Bernards, University of California, San Francisco, U.S.A.. Author(s): D. A. Bernards, K. D. Lance, N. A. Ciaccio, E. Chan, S. Rofagha, R. B. Bhisitkul, T. A. Desai. VIEW ABSTRACT

32  Flt1 Peptide – Hyaluronic Acid Conjugate Micelle-Like NanoparticlesEncapsulating Genistein for the Treatment of Occular Neovascularization. Presenter: Hyemin Kim, POSTECH, KOREA. Author(s): H. Kim, J. Choi, K. Kim, J. Yang, C. Joo, S. Hahn. VIEW ABSTRACT

33  Recombinant Cell Penetrating Peptide Construct for Targeting Mildly Acidic pH. Presenter: Likun Fei, Department of Pharmacology and Pharmaceutical Sciences, University of Southern California, U.S.A.. Author(s): L. Fei, J. L. Zaro, W. Shen. VIEW ABSTRACT

Bioactive Materials: Oral Controlled Release     [RETURN TO TOP]

34  Invited Speaker: Exploiting the Biology of Microbial Toxins for Protein Delivery. Presenter: Randall Mrsny, University of Bath, UNITED KINGDOM. Author(s): R. Mrsny. VIEW ABSTRACT

35  Oral disposition of G3.5 PAMAM dendrimer across mice intestinal epithelia and anticancer activity of its drug conjugate. Presenter: Giridhar Thiagarajan, University of Utah, U.S.A.. Author(s): G. Thiagarajan, A. Ray, L. Götz, D. A. Hubbard, S. Sadekar, R. A. Price, H. Ghandehari. VIEW ABSTRACT

36  Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus. Presenter: yuan huang, Key Laboratory of Drug Targeting and Drug Delivery System, Ministry of Education, West China School of Pharmacy, Sichuan University, PRC PEOPLES REP OF CHINA. Author(s): Y. Huang. VIEW ABSTRACT

37  Tailored Controlled Release by Printing of Drug Substances and Polymer Layers. Presenter: Niklas Sandler, Abo Akademi University, Turku, Finland, FINLAND. Author(s): N. Genina, D. Fors, H. Vakili, P. Ihalainen, J. Peltonen, N. Sandler. VIEW ABSTRACT

38  Foam Hot Melt Extrusion of an Eudragit - Nifedipine Matrix Formulation using Supercritical CO2. Presenter: Tony Listro, Foster Corporation, U.S.A.. Author(s): T. Listro, T. Kane, A. Adegoke, A. Sarode, P. Wang. VIEW ABSTRACT

C&DP: Hydrogel Delivery Systems in Consumer Products     [RETURN TO TOP]

39  Invited Speaker: Contact Lenses for Delivery of Drugs to the Front and Back of the Eye. Presenter: Heather Sheardown, McMaster Univ, CANADA. Author(s): H. Sheardown, L. Liu, L. Subbaraman, G. Guidi, A. Hui. VIEW ABSTRACT

40  Extended Release of DMPC from Silicone Hydrogel Contact Lenses. Presenter: William Pitt, Brigham Young University, U.S.A.. Author(s): W. G. Pitt, Y. Zhao, K. X. Perez, D. R. Jack, J. Lee, J. L. Nelson, J. D. Pruitt. VIEW ABSTRACT

41  Hydrogels with Enhanced Mechanical Properties Using End-Group Modified Pluronic F127 Blend System. Presenter: Seung Yong Lee, Seoul National University, KOREA. Author(s): S. Lee, J. Kim, C. Ahn. VIEW ABSTRACT

42  Increased release time of diclofenac loaded into a cross-linked hyaluronic acid hydrogel. Presenter: Ole Dall, Novozymes Biopharma DK, DENMARK. Author(s): M. J. Maltesen, M. Larsen, F. Longin, O. Dall. VIEW ABSTRACT

43  Mechanical characterization of mucoadhesive liquid crystalline systems for buccal drug delivery.. Presenter: Marlus Chorilli, State University of São Paulo, BRAZIL. Author(s): M. Chorilli, G. Calixto, M. Garcia. VIEW ABSTRACT

Mini Symposia: Recombinant Polymers - Macromolecules from Microbes     [RETURN TO TOP]

44  Invited Speaker: Protein Polymers and Their Design and Production for Medical Applications. Presenter: Joseph Cappello, University of Utah, U.S.A.. Author(s): J. Cappello. VIEW ABSTRACT

45  Invited Speaker: Design of Elastin-like Polypeptides for Drug Delivery. Presenter: Ashutosh Chilkoti, Duke University, U.S.A.. Author(s): A. Chilkoti. VIEW ABSTRACT

46  Invited Speaker: Silk Protein Stabilization and Delivery Systems. Presenter: David Kaplan, Tufts University, U.S.A.. Author(s): D. L. Kaplan. VIEW ABSTRACT

47  Invited Speaker: Formulation Development for the Production of Efficient PEGylated-Targeted Nanoparticles. Presenter: Arash Hatefi, Rutgers University, U.S.A.. Author(s): A. Hatefi, Z. Karjoo, H. McCarthy. VIEW ABSTRACT

Bioactive Materials: DNA and RNAi Delivery     [RETURN TO TOP]

48  Invited Speaker: Development of biodegradable peptide-based polymers for nucleic acid delivery to the CNS. Presenter: Suzie Pun, University of Washington, U.S.A.. Author(s): D. Chu, J. G. Schellinger, J. Shi, H. Wei, D. Sellers, P. Horner, S. H. Pun. VIEW ABSTRACT

49  Development and In Vivo Expression of PEGylated Polyacridine Polyplexes. Presenter: Kevin Rice, Division of Medicinal and Natural Products Chemistry, College of Pharmacy, University of Iowa, U.S.A.. Author(s): K. G. Rice, K. Kizzire, S. Khargharia. VIEW ABSTRACT

50  Local Delivery of Anti-Apoptotic BNIP3 siRNA by BioreduciblePolymers Retains Heart Function after Myocardial Infarction in Rats. Presenter: Arlo McGinn, University of Utah Department of Pharmacology and Toxicology and Department of Pharmaceutics and Pharmaceutical Chemistry Center for Controlled Chemical Delivery, U.S.A.. Author(s): A. N. McGinn, D. A. Bull, S. Kim. VIEW ABSTRACT

51  Generation of protective immune response against the P815 tumor by DNA electrotransfer. Presenter: Gaelle Vandermeulen, UCLouvain, Louvain Drug Research Institute, Pharmaceutics and Drug Delivery, BELGIUM. Author(s): G. Vandermeulen, C. Uyttenhove, E. De. Plaen, B. Van den Eynde, V. Preat. VIEW ABSTRACT

52  High-content screening of peptide-based non-viral gene delivery systems. Presenter: Markus de Raad, PhD student, NETHERLANDS. Author(s): M. de Raad, E. A. Teunissen, D. Lelieveld, D. A. Egan, E. Mastrobattista. VIEW ABSTRACT

Bioactive Materials: Drug Delivery to the Brain     [RETURN TO TOP]

53  Invited Speaker: The blood-brain barrier, a bridge too far? Presenter: Laurent Lecanu, McGill Univ, CANADA. Author(s): L. Lecanu. VIEW ABSTRACT

54  PET-based approaches to studying the size-dependence of leptomeningeal drug clearance. Presenter: Elena Belova, Massachusetts General Hospital, U.S.A.. Author(s): E. Belova, L. Vallance, V. Belov, M. Gagne, C. Gillooly, M. Papisov. VIEW ABSTRACT

55  Enhanced brain delivery of liposomal methylprednisolone is beneficial for the treatment of neuroinflammation in an animal model of multiple sclerosis. Presenter: Chantal Appeldoorn, to-BBB technologies BV, NETHERLANDS. Author(s): C. C. Appeldoorn, P. J. Gaillard, J. Rip, R. Dorland, S van der Pol, G. Kooij, H. E. de Vries, A. Reijerkerk. VIEW ABSTRACT

56  Delivery of enzyme replacement therapeutics to CNS in rats and monkeysas seen and measured by PET. Presenter: Mikhail Papisov, Massachusetts General Hospital and Harvard Medical School, U.S.A.. Author(s): M. I. Papisov, V. Belov, A. Fischman, J. Titus, M. Gagne, P. Calias, T. McCauley, M. Heartlein. VIEW ABSTRACT

57  Zero-order Release of A Novel Antipsychotic from PLGA-based Microsphere. Presenter: Lexi Wang, Jilin University, PRC PEOPLES REP OF CHINA. Author(s): L. Wang, X. Zhao, X. Liu, D. Wang, Z. Su, F. Sun, Y. Li. VIEW ABSTRACT

Bioactive Materials: Intracellular Processes     [RETURN TO TOP]

58  Invited Speaker: Sub-Cellular Transport of Drug Delivery Systems: an Intricate Road. Presenter: SIlvia Muro, University of Maryland, U.S.A.. Author(s): S. Muro. VIEW ABSTRACT

59  PLGA micro or nanoparticles differently induce inflammatory response in murine macrophages. Presenter: Roberto Nicolete, Oswaldo Cruz Foundation, BRAZIL. Author(s): R. Nicolete, D. F. dos Santos, L. H. Faccioli. VIEW ABSTRACT

61  Optimization of quantitative tools to study Polymer Conjugate cell trafficking. Presenter: Ana Armiñán, Polymer Therapeutics Lab, Centro de Investigación Principe Felipe (CIPF), SPAIN. Author(s): A. Armiñán, M. Vicent, C. Deladriere, M. Palomino, A. Pineda. VIEW ABSTRACT

62  Intercellular transfer of nano and micro-particles in endothelial cells. Presenter: Silvia Ferrati, The Methodist Hospital Research Institute, Houston, TX , U.S.A.. Author(s): S. Ferrati, A. C. Mack, N. Sirisaengtaksin, J. Schmulen, H. D. Summers, P. Rees, X. Liu, A. J. Bean, M. Ferrari. VIEW ABSTRACT

C&DP: Consumer and Industrial Applications of Nanoparticle Technology     [RETURN TO TOP]

63  Invited Speaker: Advances of Sub-micron Particle Technologies for Consumer and Industrial Applications. Presenter: Fanwen Zeng, The Dow Chemical Co, U.S.A.. Author(s): F. Zeng. VIEW ABSTRACT

64  Mild drying and encapsulation by electrospinning. Presenter: Robert Tromp, NIZO food research, NETHERLANDS. Author(s): R. H. Tromp. VIEW ABSTRACT

65  ART nanocrystals - a novel simple method for the production of nanocrystals in industrial scale. Presenter: Rainer Müller, Free University of Berlin, Kelchstrasse 31, Berlin12169, Germany, GERMANY. Author(s): R. Chen, Ö. Kumanova, C. M. Keck, R. H. Müller. VIEW ABSTRACT

66  Improvement of In Vitro Efficacy of Ascorbyl Glucoside by Encapsulation in QD Compliant Cationic Liposome. Presenter: Florent Durieux, BASF Beauty Care Solutions, FRANCE. Author(s): F. Durieux, I. Bonnet, N. Godard, E. Nappi, B. Vogelgesang, V. Andrá-Frei. VIEW ABSTRACT

67  Encapsulated liquid lubricants for production of self-lubricating surfaces. Presenter: Ruth Schmid, SINTEF Materials and Chemistry, Department of Synthesis and Properties, NORWAY. Author(s): R. Schmid, S. Armada, S. Equey, H. Johnsen, N. Espallargas. VIEW ABSTRACT

Mini Symposia: Morphologies and Cell Responses     [RETURN TO TOP]

68  Invited Speaker: The role of nanoparticle design in mediating blood and cellular interactions, and tumor targeting. Presenter: Warren Chan, Toronto Univ, CANADA. Author(s): W. Chan. VIEW ABSTRACT

69  Invited Speaker: Toxicity, Cellular Uptake, and Biodistribution of Inorganic Nanomaterials: Does Shape Matter? Presenter: Hamid Ghandehari, University of Utah, U.S.A.. Author(s): H. Ghandehari, T. Yu, H. L. Herd, A. Gormley, A. Ray. VIEW ABSTRACT

70  Invited Speaker: Engineering Morphology of Drug Carriers for Controlling Biological and Therapeutic Outcomes. Presenter: Samir Mitragotri, University of California, Santa Barbara, U.S.A.. Author(s): S. Mitragotri. VIEW ABSTRACT

71  Invited Speaker: Three-Dimensional DNA Structures: Loading and Selective Release of Cargo and Enhanced Cellular Uptake. Presenter: Hanadi Sleiman, McGill University, CANADA. Author(s): H. Sleiman. VIEW ABSTRACT

Bioactive Materials: Inorganic Nanosystems     [RETURN TO TOP]

72  Invited Speaker: Gold Nanoparticles for Drug, Gene and Protein Delivery. Presenter: Vincent Rotello, University of Massachusetts Amherst, U.S.A.. Author(s): V. M. Rotello. VIEW ABSTRACT

73  Comparison of mesoporous silicon micro- and nanoparticles for subcutaneous peptide delivery. Presenter: Juha Mönkäre, University of Eastern Finland, FINLAND. Author(s): J. Mönkäre, M. Kovalainen, E. Mäkilä, M. Kaasalainen, K. Herzig, V. Lehto, J. Salonen, K. Järvinen. VIEW ABSTRACT

74  Target Specific Systemic Delivery of siRNA and Interferon a Using Gold Nanoparticles for the Treatment of Liver Diseases. Presenter: Min-Young Lee, Department of Material Science & Engineering, POSTECH, SOUTH KOREA. Author(s): M. Lee, K. Park, J. Yang, S. Hahn. VIEW ABSTRACT

75  In vivo biodistribution and pharmacokinetics of silica nanoparticles as a function of geometry, porosity and surface charge. Presenter: Tian Yu, University of Utah, U.S.A.. Author(s): T. Yu, D. Hubbard, A. Ray, H. Ghandehari. VIEW ABSTRACT

304  Nanocomposites Based On Montorillonite, Chitosan And Silver Sulfadiazine Intended For Wound Healing. Presenter: Carla Caramella, Department of Drug Sciences, University of Pavia, ITALY. Author(s): G. Sandri, M. Bonferoni, C. Aguzzi, P. Cerezo, F. D'Autilia, S. Rossi, F. Ferrari, C. Viseras, C. Caramella. VIEW ABSTRACT

Bioactive Materials: Oncology and Tumor Targeting     [RETURN TO TOP]

76  Invited Speaker: Design of a produg of mitomycin C for liposomal delivery: From bench to bedside. Presenter: Alberto Gabizon, Shaare Zedek Medical Center and Hebrew University, ISRAEL. Author(s): A. Gabizon, Y. Amitay, H. Shmeeda. VIEW ABSTRACT

77  Uncovering tumor-host molecular and cellular interactions involved in tumor dormancy using polymer therapeutics. Presenter: Ronit Satchi-Fainaro, Department of Physiology and Pharmacology, Sackler School of Medicine, Tel Aviv University, ISRAEL. Author(s): G. Tiram, E. Segal, R. Shreberk, G. Bachar, P. Ofek, L. Edry, N. Shomron, H. Pan, P. Kopecková, J. Kopecek, T. Udagawa, R. Satchi-Fainaro. VIEW ABSTRACT

78  Mixed Micelles of Triblock Copolymers for overcoming multidrug resistance in cancer. Presenter: Tae Hee Kim, Korea Institute of Industrial Technology, KOREA. Author(s): T. Kim, C. W. Mount, B. W. Dulken, M. Du, W. Gombotz, S. H. Pun. VIEW ABSTRACT

79  Electrophoretic Disruption of Nonspecific Peptide Interactions with MMP-Sensitive Hydrogels. Presenter: Richard Gemeinhart, University of Illinois, U.S.A.. Author(s): Y. Zhang, R. A. Gemeinhart. VIEW ABSTRACT

80  Development of novel tumoral pH responsive nanoparticles for cancer therapy. Presenter: Susumu Hama, Department of Biophysical Chemistry, Kyoto Pharmaceutical University, JAPAN. Author(s): S. Hama, S. Itakura, M. Nakai, K. Nakayama, S. Morimoto, H. Tsuchiya, K. Kogure. VIEW ABSTRACT

Bioactive Materials: Transdermal Drug Delivery     [RETURN TO TOP]

81  Invited Speaker: Improving the Bioavailability of Topically and Transdermally Delivered Drugs. Presenter: Richard Guy, University of Bath, UNITED KINGDOM. Author(s): R. H. Guy. VIEW ABSTRACT

82  Imaging Topically Applied Particles to Porated Skin with Coherent Raman Scattering and Two Photon Fluorescence Microscopy. Presenter: Natalie Belsey, University of Bath, Department of Pharmacy and Pharmacology, UNITED KINGDOM. Author(s): N. A. Belsey, L. Contreras-Rojas, G. J. Price, N. L. Garrett, J. Moger, R. H. Guy. VIEW ABSTRACT

83  Clinical Assessment of AK following Levulan and BLU-U Photodynamic Therapy after Pre-treatment with a Sterile, Plastic Microneedle Device (MSSTM). Presenter: Kris Hansen, 3M Drug Delivery Systems, U.S.A.. Author(s): K. Hansen, C. Novak, C. Moeckly, T. Martin. VIEW ABSTRACT

84  Localized Drug Delivery through Mammary Papilla. Presenter: Kaushalkumar Dave, Department of Pharmaceutical Sciences, South Dakota State University, U.S.A.. Author(s): K. Dave, P. Sahdev, O. Perumal, K. Bruns. VIEW ABSTRACT

85  Induced Accumulation of Diflucortolone Valerate in Rat Skin by Lecithin-Chitosan Nanoparticles. Presenter: Ozgen Ozer, Ege University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Izmir, TURKEY. Author(s): T. Senyigit, I. Ozcan, M. Ozyazici, O. Ozer. VIEW ABSTRACT

C&DP: Nutraceuticals and Functional Foods     [RETURN TO TOP]

86  Invited Speaker: Keynote Address, Nutriceuticals and Functional Foods. Presenter: Howard Wheeler, Color Wheel Inc, U.S.A.. Author(s): H. S. Wheeler. VIEW ABSTRACT

88  The Influence of Calcium Carbonate in Tablet Coating Systems. Presenter: Beverly Schad, Sensient Technologies, U.S.A.. Author(s): B. A. Schad. VIEW ABSTRACT

89  Formation of Riboflavin/beta-lactoglobulin Nanocomplex and Impact on Riboflavin’s Photo-Activation. Presenter: Fatoumata Diarrassouba, STELA/INAF, Universitá Laval, Quábec, QC, Canada, CANADA. Author(s): F. Diarrassouba, L. Liang, G. E. Remondetto, M. Subirade. VIEW ABSTRACT

90  Multilayer alginate-chitosan microcapsules for the effective oral delivery of probiotic Bifidobacterium. Presenter: Michael Cook, University of Reading, UNITED KINGDOM. Author(s): M. T. Cook, G. Tzortzis, V. V. Khutoryanskiy, D. Charalampopoulos. VIEW ABSTRACT

Mini Symposia: Smart Textiles     [RETURN TO TOP]

93  Invited Speaker: Understanding Compression Burn and Achieve High Thermal Protective Performance. Presenter: Guowen SONG, University of Alberta, CANADA. Author(s): G. Song. VIEW ABSTRACT

94 Invited Speaker: Microcapsule Delivery Systems for Textile Applications. Presenter: Teresa Virgallito, Microtek Laboratories, Inc., U.S.A.. Author(s): T. Virgallito. VIEW ABSTRACT

Bioactive Materials/C&DP: Nanofibers/Nanoparticles     [RETURN TO TOP]

95  Invited Speaker: High Voltage Output Nanogenerator Based on PZT Nanofibers. Presenter: Yong Shi, Stevens Inst of Technology, U.S.A.. Author(s): Y. Shi. VIEW ABSTRACT

96  Nano-Structured Microparticles for Prolonged Residence Time on Preocular Surface. Presenter: Chun Gwon Park, Interdisciplinary Program in Bioengineering, College of Engineering, Seoul National University, Seoul, Republic of Korea. Author(s): C. Park, M. Park, J. Lee, S. Lee, G. Shin, Y. Choy. VIEW ABSTRACT

97  Polymeric Nanofibers Co-loaded with Fusidic Acid & Rifampicin for the Prevention of Implant Associated Infections. Presenter: Samuel Gilchrist, Faculty of Pharmaceutical Sciences, The University of British Columbia, CANADA. Author(s): S. E. Gilchrist, D. Lange, H. Bach, L. Fazli, Y. Av-Gay, H. M. Burt. VIEW ABSTRACT

98  Functionalized Nanoparticle Release and Distribution in PEG Hydrogel Delivery Systems. Presenter: Stephanie Hume, National Institute of Standards and Technology, U.S.A.. Author(s): S. L. Hume, J. L. Blacklock, K. M. Jeerage. VIEW ABSTRACT

99  Cross-linked Resins by Stepwise Polyaddition of beta-Cyclodextrin with Bisacrylamides and Assessment of Their Potential as pH-Sensitive NPs for Site-Specific Protein Delivery. Presenter: Elisabetta Ranucci, University of Milan, ITALY. Author(s): E. Ranucci, P. Ferruti, A. Manfredi, R. Cavalli. VIEW ABSTRACT

Bioactive Materials: Stem Cell and Regenerative Medicines     [RETURN TO TOP]

100  Invited Speaker: Engineering Bioactive Materials to Control Stem Cell Self-Renewal and Differentiation. Presenter: David Schafer, University of California, Berkeley, U.S.A.. Author(s): D. Schafer. VIEW ABSTRACT

594 Thermoreversible Hydrogels as a Drug Release Platform in Degenerative Disc DiseasePresenter: Eric Craenmehr, TNO, Netherlands. Author(s): J Eversdijk. VIEW ABSTRACT

102  Controlled Release of Bioactive PDGF-AA from PLGA Nanoparticles. Presenter: Irja Elliott Donaghue, Department of Chemical Engineering & Applied Chemistry, Institute of Biomaterials & Biomedical Engineering, University of Toronto, CANADA. Author(s): I. Elliott. Donaghue, T. Zahir, M. S. Shoichet. VIEW ABSTRACT

103  Evaluation of Antibiotic-releasing Porous Polymethylmethacrylate Space Maintainers in an Infected Composite Tissue Defect. Presenter: Patrick Spicer, Rice University, U.S.A.. Author(s): P. P. Spicer, A. M. Henslee, L. A. Kinard, B. M. Watson, J. D. Kretlow, K. Bevil, L. Katchee, J. A. Jansen, M. E. Wong, F. K. Kasper, A. G. Mikos. VIEW ABSTRACT

104  The effect of exopolysaccharides extrated from Botryosphaeria rhodina on bone tissue engineering. Presenter: Hsin-I Chang, Department of Biochemical Science and technology, Chiayi University, TAIWAN. Author(s): H. Chang. VIEW ABSTRACT

Bioactive Materials: Theranostics and Cancer Nanotechnologies     [RETURN TO TOP]

105  Invited Speaker: Carbon Nanotubes for Theranostic Applications. Presenter: Xiaoyuan Chen, National Institutes of Health, U.S.A.. Author(s): X. Chen. VIEW ABSTRACT

106  Tumor Cell-Specific Delivery of Paclitaxel Using a Self-assembled Matrix Metalloprotease 2-sensitive Nanocarrier. Presenter: Lin Zhu, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, U.S.A.. Author(s): L. Zhu, A. Taigind, V. P. Torchilin. VIEW ABSTRACT

107  Ultrasound-Induced Release from eLiposomes at 20 kHz. Presenter: William Pitt, Brigham Young University, U.S.A.. Author(s): W. G. Pitt, J. R. Lattin. VIEW ABSTRACT

108  Gas-Generating Calcium Carbonate Mineralized Nanoparticles for Ultrasound Imaging. Presenter: Kyung Hyun Min, Departmemt of Life and Nanopharmaceutical Science, Kyung Hee University, SOUTH KOREA. Author(s): K. Min, S. Jeong, S. Lee. VIEW ABSTRACT

109  Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise for use in drug-resistant cancer therapy. Presenter: Hiroto Hatakeyama, Faculty of Pharmaceutical Sciences, Hokkaido University, JAPAN. Author(s): H. Hatakeyama, K. Takara, G. Kibria, N. Ohga, K. Hida, H. Harashima. VIEW ABSTRACT

Bioactive Materials: Translational Nanomedicine     [RETURN TO TOP]

110  Invited Speaker: Targeting G Protein-Coupled Receptor Folding and their Export from the Endoplasmaic Reticulum for the Treatment of Conformational Diseases. Presenter: Michel Bouvier, University of Montráal, CANADA. Author(s): M. Bouvier, P. Rená, É. Sauvageau, M. Palardy, J. Morello, V. Bernier. VIEW ABSTRACT

111  In vivo assessment of salmon calcitonin nanoparticles delivered by the intra-articular route for treatment of inflammatory arthritis in the K/BxN mouse model. Presenter: David Brayden, University College Dublin, IRELAND. Author(s): S. M. Ryan, H. Patel, K. Kornerup, A. Umerska, L. Tajber, M. Perretti, D. J. Brayden. VIEW ABSTRACT

112  Usability and Acceptability of a Placebo Microneedle Patch for Self-Vaccination Against Influenza in Naïve Human Subjects. Presenter: James Norman, Georgia Institute of Technology, U.S.A.. Author(s): J. J. Norman, M. A. McClain, P. M. Frew, M. R. Prausnitz. VIEW ABSTRACT

113  Loperamide-Formulated Immunoliposomes Directed Towards Intercellular Adhesion Molecule-1 (ICAM-1): A Potential Tool for Specific Drug Delivery to Peripheral Inflammatory Pain. Presenter: Susan Hua, The University of Newcastle, AUSTRALIA. Author(s): S. Hua, P. J. Cabot. VIEW ABSTRACT

114  Chitosan-PEG-folate-conjugated oncolytic adenovirus for targeted cancer gene therapy. Presenter: Chae-Ok Yun, Department of Bioengineering, College of Engineering, Hanyang University, KOREA. Author(s): O. Kwon, E. Kang, J. Choi, S. Kim, C. Yun. VIEW ABSTRACT

658  PLGA Nanoparticle Property-Biodistribution Relationships and In Vivo Degradation. Presenter: J Reineke, Wayne State University, U.S.A.. Author(s): M. Li, A. Mohammad, J. Reineke. VIEW ABSTRACT

Mini Symposia: New Chemistries - Click It, Fit It, Test It     [RETURN TO TOP]

115  Invited Speaker: Combinatorial development of biomaterials and synthetic siRNA delivery systems. Presenter: Daniel Anderson, MIT, U.S.A.. Author(s): D. G. Anderson. VIEW ABSTRACT

116  Invited Speaker: A Bioactive Peptide that signals against Phagocytic Clearance to Maximize Delivery. Presenter: Dennis Discher, University of Pennsylvania, U.S.A.. Author(s): D. E. Discher. VIEW ABSTRACT

117  Invited Speaker: Azlactone-Containing Polymer Multilayers as Reactive, Modular, and Tunable Platforms for Surface-Mediated Drug Delivery. Presenter: David Lynn, University of Wisconsin - Madison, U.S.A.. Author(s): D. M. Lynn. VIEW ABSTRACT

118  Invited Speaker: Nanoscale Amphiphilc Macromolecules: Designing compounds to inhibit oxidized low-density lipoprotein uptake. Presenter: Kathryn Uhrich, Rutgers University, U.S.A.. Author(s): K. Uhrich. VIEW ABSTRACT

 

POSTER PRESENTATIONS

Imaging Diagnostics for Material Characterization     [RETURN TO TOP]

119  Analysis of particle agglomeration and content uniformity by Raman imaging. Presenter: Oksana Olkhovyk, Gateway Analytical, LLC., U.S.A.. Author(s): O. Olkhovyk. VIEW ABSTRACT

122  Relating the influence of temperature and humidity on the surface characteristics of a spray-dried polymeric matrix consisting of poly(lactic-co-glycolic acid) and polyvinylpyrrolidone to the thermal characteristics of these polymers. Presenter: Joke Meeus, KU Leuven, BELGIUM. Author(s): J. Meeus, D. J. Scurr, X. Chen, V. Ciarnelli, M. C. Davies, C. J. Roberts, G. Van den Mooter. VIEW ABSTRACT

123  Size and Count Characterization of Drug Delivery Nanoparticles by Nanoparticle Tracking Analysis. Presenter: Sonja Capracotta, NanoSight USA, U.S.A.. Author(s): S. Capracotta, D. A. Griffiths, P. Hole. VIEW ABSTRACT

124  Solubility Enhancement of Atorvastatin Calcium by Solid Dispersions Using Hot Melt Extrusion. Presenter: Viraj Kulthe, National Institute of Medical Sciences University, Rajasthan, INDIA. Author(s): V. V. Kulthe, P. D. Chaudhari, S. Chakraborty. VIEW ABSTRACT

125  Study on Hollow Silica Nanospheres as Ultrasound Contrast Agent. Presenter: Fang-Ying Chu, Tse-Ying Liu, TAIWAN. Author(s): F. Chu, T. Liu. VIEW ABSTRACT

Biomaterials     [RETURN TO TOP]

127  A Drug-Eluting Contact Lens. Presenter: Joseph Ciolino, Massachusetts Eye and Ear Infirmary, U.S.A.. Author(s): J. B. Ciolino, C. F. Stefanescu, K. A. Wymbs, S. S. Sprague, D. R. Mascoop, S. S. Rudina, F. Cade. VIEW ABSTRACT

130  A Smart Gel Based Controlled Release of Insulin. Presenter: Akira Matsumoto, Tokyo Medical and Dental University, JAPAN. Author(s): A. Matsumoto, T. Ishii, K. Kataoka, Y. Miyahara. VIEW ABSTRACT

131  A Stable Formulation of Glucagon for Pump Use. Presenter: Ming Li, Biodel inc., U.S.A.. Author(s): M. Li, R. Pohl, Y. Yang, C. Dilak, P. Reddy. VIEW ABSTRACT

132  A user-friendly injectable sustained-release formulation for Triptorelin. Presenter: Lutz Asmus, University of Geneva, SWITZERLAND. Author(s): L. R. Asmus, B. Kaufmann, L. Melander, T. Weiss, W. Koechling, G. Schwach, R. Gurny, M. Möller. VIEW ABSTRACT

133  Bacterial Nanocellulose as Active Wound Dressing for Controlled Release of Antiseptics. Presenter: Dagmar Fischer, Institute of Pharmacy, Department of Pharmaceutical Technology, Friedrich-Schiller-University, GERMANY. Author(s): S. Moritz, C. Wiegand, M. Munteanu, A. Müller, N. Hessler, D. Kralisch, U. Hipler, D. Fischer. VIEW ABSTRACT

134  Biodegradable hydrophilic SynBiosys Pro monospheres for long-term parenteral delivery of proteins. Presenter: Christine Hiemstra, InnoCore Pharmaceuticals, NETHERLANDS. Author(s): C. Hiemstra, M. Staal, A. Lathuile, G. J. Veldhuis, R. Steendam. VIEW ABSTRACT

135  Biodegradable Microsphere Platform for the Delivery of Bioactive Compounds. Presenter: Maarten Dijk, DSM Ahead, NETHERLANDS. Author(s): M. V. Dijk, R. Licht, L. Creemers, D. Schumann, M. Hendriks. VIEW ABSTRACT

136  Biodegradable monodisperse microspheres with sustained release of goserelin acetate for the treatment of prostate and breast cancer. Presenter: Luisa Duque, InnoCore Pharmaceuticals, NETHERLANDS. Author(s): L. F. Duque, A. Lathuile, M. F. Limousin, E. Klijnstra, R. Steendam, G. J. Veldhuis. VIEW ABSTRACT

137  Biodegradable Thermoresponsive Nanogels as Intravitreal Injection Carrier for Bevacizumab. Presenter: Hsia-Wei Liu, Fu Jen Catholic University, TAIWAN REP OF CHINA. Author(s): H. Liu, Y. Kui, J. Chaw, C. Hu. VIEW ABSTRACT

138  Biomimeticdesign of lubricin-like polymers for lubrication of articular joints. Presenter: Mingchee Tan, Cornell University, U.S.A.. Author(s): M. Tan. VIEW ABSTRACT

140  Carboxymethylchitosan and poly(γ-glutamic acid) conjugated stimuli-responsive polymers for protein delivery. Presenter: Shu-Huei Yu, Department of Materials Science and Engineering, Vanung University, Chung-Li, Taiwan, TAIWAN. Author(s): S. Yu, D. Tang, Mi, Y. Ho, Y. Su, A. Chao. VIEW ABSTRACT

141  Cellular Uptake of the Cysteine-rich Cell Penetrating Peptide CyLoP-1 depends on the Availability of Exofacial Protein Thiols. Presenter: Sven Gottschalk, Max Planck Institute for Biological Cybernetics, GERMANY. Author(s): S. Gottschalk, M. Petrovic, D. Jha, J. Engelmann. VIEW ABSTRACT

142  Chitosan Modified with Membrane-Permeable and Intracellular Reducible Molecules for Gene Delivery. Presenter: Yi-Cheng Ho, Department of Biotechnology, Vanung University, Chung-Li, Taiwan , TAIWAN. Author(s): Y. Ho, F. Mi, S. Yu, D. Tang, H. Sung, P. Lin. VIEW ABSTRACT

143  Chitosan/Alginate Composite Scaffolds Based on Microparticles. Presenter: Selva Hizmetli, Hacettepe University Faculty of Pharmacy Department of Pharmaceutical Technology, Turkey. Author(s): S. B. Hizmetli, S. Senel. VIEW ABSTRACT

144  Clinical and Microbiological Evaluation of Biodegradable Poly (ethylene sebacate) Periodontal Implants of Roxithromycin. Presenter: Vilas Malode, Institute of Chemical Technology, INDIA. Author(s): A. B. More, V. N. Malode, V. C. Malshe, S. B. Majee, D. G. Pol, P. V. Devarajan. VIEW ABSTRACT

145  Closed Loop Insulin Delivery in Diabetic Pigs using a Smart Biomaterial Device. Presenter: M Joan Taylor, The School of Pharmacy, De Montfort University, UNITED KINGDOM. Author(s): M. Taylor. VIEW ABSTRACT

146  Control of Microparticles Morphology for Tunable Drug Release. Presenter: Daniel Palmer, Q CHIP LIMITED, UNITED KINGDOM. Author(s): I. Cheung, P. Seaman, D. Palmer. VIEW ABSTRACT

147  Controlled Release and Reloading of Doxorubicin Using an Tunable Affinity-Based Polymer System. Presenter: Andrew Fu, Case Western Reserve University, U.S.A.. Author(s): A. S. Fu, H. von. Recum. VIEW ABSTRACT

148  Controlled Release of bFGF from Chemically-crosslinked Chitosan/Pluronic Hydrogel Containing Heparin. Presenter: Sujin Yoon, Kangwon National University, KOREA. Author(s): S. Yoon, J. Choi, H. Kim, Y. Son, E. Jo, Y. Kim, J. Kang, H. Yoo. VIEW ABSTRACT

149  Controlled release of chondroitinase ABC to the injured spinal cord. Presenter: Malgosia Pakulska, University of Toronto, CANADA. Author(s): M. Pakulska, K. Vulic, M. S. Shoichet. VIEW ABSTRACT

150  Controlling Drug Release Kinetics from Soft Nanocomposite Hydrogels. Presenter: Daryl Sivakumaran, McMaster University, CANADA. Author(s): D. Sivakumaran, T. Oszustowicz, D. Maitland, T. Hoare. VIEW ABSTRACT

151  Controlling the Release of A Naturally Occurring Antioxidant from N,O-carboxymethylchitosan and Methylcellulose Composite Films. Presenter: Shu-Huei Yu, Department of Materials Science and Engineering, Vanung University, Chung- Li, Taiwan , TAIWAN. Author(s): D. Tang, F. Mi, S. Yu, Y. Ho, Y. Su, A. Chao. VIEW ABSTRACT

152  Cross-linked Nanoassemblies for Customized Drug Delivery. Presenter: Younsoo Bae, University of Kentucky, U.S.A.. Author(s): Y. Bae. VIEW ABSTRACT

154  Design and characterization of biodegradable polymer-coated protein microparticles by spray drying method with a three-fluid nozzle. Presenter: Feng Wan, Department of Pharmaceutics and Analytical Chemistry, Faculty of Health and Medical Sciences, University of Copenhagen, DENMARK. Author(s): F. Wan. VIEW ABSTRACT

155  Development of a Subcutaneous Implant using Polyurethane as a Semi-Permeable Membrane for the Controlled Release of Risperidone. Presenter: Alexander Schwarz, Endo Pharmaceuticals Inc., U.S.A.. Author(s): A. Schwarz, S. Thoroughman, D. Winstead, J. Varughese, S. Decker. VIEW ABSTRACT

158  Drug release control of photo-sensitive smart hydrogels driven by pH-jump reaction. Presenter: Takao Aoyagi, National Institute for Materials Science, JAPAN. Author(s): T. Aoyagi, M. Ebara, P. Techawanitchai. VIEW ABSTRACT

159  Drug-delivery Surgical Sutures for Post-Surgical Pain Relief. Presenter: Ji Eun Lee, Interdisiplinary Program in Bioengineering, College of Engineering, Seoul National University, Seoul, SOUTH KOREA. Author(s): J. Lee, S. Park, C. Park, M. Kim, M. Park, S. Lee, C. Heo, Y. Choy. VIEW ABSTRACT

160  Effect of the mixture of herbal honey and water-soluble chitosan on the immunity reaction of mice infected with atopy. Presenter: Jae-Woon Nah, Sunchon National University, KOREA. Author(s): J. Nah, M. Jang. VIEW ABSTRACT

163  Enzymatic synthesis of antibody-human serum albumin (mAb-HSA) conjugates for targeted drug delivery devices. Presenter: Alexandra Rollett, Graz University of Technology, AUSTRIA. Author(s): A. Rollett, B. Thallinger, A. Repic, D. Schiffer, E. Walenta, R. Birner-Gruenberger, J. G. Bogner-Strauss, A. Cavaco-Paulo, H. Stockinger, G. M. Guebitz. VIEW ABSTRACT

164  Evaluation of a Perforated Drug Delivery System in Mice for Prolonged and Constant Release of a Hydrophilic Drug. Presenter: Ashish Rastogi, The University of Texas at Austin / Us Army Institute of Surgical Research, U.S.A.. Author(s): A. Rastogi, P. D. Bowman, S. Stavchansky. VIEW ABSTRACT

165  Formulation and Evaluation of Microencapsulated Hydrogen Peroxide for Controlled Release of Oxygen. Presenter: Hye-Young Chang, Bio-Medical Research Institute, Kyungpook National University School of Medicine, KOREA. Author(s): H. Chang, J. Choi, T. Kwon, J. J. Yoo, J. Lim. VIEW ABSTRACT

166  IGF-1 loaded monospheres for treating ischemic heart disease. Presenter: Christine Hiemstra, InnoCore Pharmaceuticals, NETHERLANDS. Author(s): C. Hiemstra, A. Lathuile, J. Zuidema, A. Funhoff, G. J. Veldhuis, R. Steendam. VIEW ABSTRACT

167  Impact of Polymer Physico-chemical Properties on PEG-grafted-PLA Nanoparticles Structure. Presenter: Jean-Michel Rabanel, Faculté de Pharmacie, Université de Montréal, CANADA. Author(s): J. Rabanel, V. Aoun, P. Hildgen. VIEW ABSTRACT

168  In Situ Supramolecular Assembly and Modular Modification of Hyaluronic Acid Hydrogels for Drug Delivery and Tissue Engineering Applications. Presenter: Sei Kwang Hahn, POSTECH, SOUTH KOREA. Author(s): S. Hahn, K. Park, J. Yang, H. Jung, K. Kim. VIEW ABSTRACT

169  In Vitro Behaviour of Composite Calcium Polyphosphate Disks Loaded with Vancomycin. Presenter: Patricia Comeau, School of Biomedical Engineering, Dalhousie University, CANADA. Author(s): P. A. Comeau, M. J. Filiaggi. VIEW ABSTRACT

170  In Vitro Degradation of Double-Walled PLA(PLGA) Microspheres. Presenter: Qingxing Xu, University of Illinois at Urbana-Champaign, U.S.A.. Author(s): Q. Xu, S. Chin, C. Wang, D. W. Pack. VIEW ABSTRACT

172  In Vivo Degradation and Tissue Response to Low Viscosity Poly(5-ethylene ketal e-caprolactone-co-D,L-lactide). Presenter: Brian Amsden, Queen's University, CANADA. Author(s): O. I. Babasola, J. Bianco, B. G. Amsden. VIEW ABSTRACT

173  Inhalable Engineered Erythrosomes as Natural Nano-Reservoirs of a Rho-kinase Inhibitor, Fasudil. Presenter: Nilesh Gupta, Texas Tech University Health Sciences Center, U.S.A.. Author(s): N. Gupta, S. A. Vanapalli, F. Ahsan. VIEW ABSTRACT

174  Inhaled PLGA Particles of Erlotinib as an Alternative to Oral Erlotinib for the Treatment of Non-small Cell Lung Cancer. Presenter: Kamrun Nahar, Texas Tech University Health Sciences Center, U.S.A.. Author(s): K. Nahar, N. Gupta, F. Ahsan. VIEW ABSTRACT

175  Injectable modular hydrogels for controlled drug binding and delivery. Presenter: Mathew Patenaude, Graduate Student, McMaster University, CANADA. Author(s): M. J. Patenaude, T. R. Hoare. VIEW ABSTRACT

176  Injectable, in-situ gelling,cyclodextrin-dextran based hydrogels for the release of hydrophobic drugs. Presenter: Todd Hoare, McMaster University, CANADA. Author(s): R. Mateen, T. Hoare. VIEW ABSTRACT

177  Lactic Acid and Carbonate-based Crosslinked Polymeric Micelles as Drug Delivery Vehicles. Presenter: Michael Danquah, University of Tennessee Health Science Center, U.S.A.. Author(s): M. Danquah, T. Fujiwara, R. I. Mahato. VIEW ABSTRACT

178  Liposomal-based nano device with cell penetrating and pH-sensitive fusogenic peptides achieves efficient and high-speed transduction of antibody into living cells. Presenter: Sandra Vergara, Hokkaido University, JAPAN. Author(s): S. M. Vergara, Y. Yamada, H. Harashima. VIEW ABSTRACT

179  Liposomes prepared from bixin as amphotericin B delivery system. Presenter: Irene Kikuchi, Faculty of Pharmaceutical Sciences/University of Sao Paulo, BRAZIL. Author(s): I. S. Kikuchi, R. O. Takamoto, M. S. Matuo, T. A. Pinto. VIEW ABSTRACT

181  Matrix Metalloproteinase Responsive Genetically Engineered Silk-Elastinlike Protein Polymers. Presenter: Joshua Gustafson, University of Utah, U.S.A.. Author(s): J. A. Gustafson, R. A. Price, J. Frandsen, J. Cappello, H. Ghandehari. VIEW ABSTRACT

182  Modulating the rheological properties of hydrogels composed of blends of hydroxyl- and hexanoyl-PCLA-PEG-PCLA triblock copolymers. Presenter: Audrey Petit, InGell Labs BV, Utrecht Institute for Pharmaceutical Sciences, NETHERLANDS. Author(s): A. Petit, B. Müller, P. Bruin, R. Meyboom, M. Piest, T. Vermonden, W. E. Hennink. VIEW ABSTRACT

183  Mussel-inspired Chitosan Nanogels with Enhanced Stability and Mucoadhesion for Drug Delivery. Presenter: Ghareb Soliman, McGill University, CANADA. Author(s): G. M. Soliman, M. Cerruti, J. Barralet. VIEW ABSTRACT

184  Nanoparticles prepared from chitosan-N-arginine and Poly(γ-glutamic acid)-taurine for oral delivery of antiangiogenic AE-941 protein. Presenter: Fwu-Long Mi, Department of Biotechnology, Vanung University, Chung-Li, Taiwan , TAIWAN. Author(s): F. Mi, Yu, Y. Ho, D. Tang, H. Sung, H. Hsieh. VIEW ABSTRACT

185  Nattokinase, an Enzyme from Japanese Food, Increases Epithelium Permeability. Presenter: Jennie Lord, University of Nottingham, UNITED KINGDOM. Author(s): J. Lord, D. Vllasaliu, S. Gaunt, F. H. Falcone, S. Stolnik. VIEW ABSTRACT

186  Non Phospholipid Liposomes Prepared from a Monoalkylated Amphiphile and a Sterol: a Versatile Family of Nanovectors. Presenter: Michel Lafleur, Université de Montréal, CANADA. Author(s): M. Lafleur, G. Carbajal, T. Phoeung, Z. Cui. VIEW ABSTRACT

187  NVP-co-DMA-co-GMA Hydrogels with Cyclodextrins for Ocular Delivery of Carbonic Anhydrase Inhibitors. Presenter: Andreza Ribeiro, University of Coimbra, PORTUGAL. Author(s): A. M. Ribeiro, F. J. Veiga, D. Santos, J. Torres-Labandeira, A. Concheiro, C. Alvarez-Lorenzo. VIEW ABSTRACT

188  On-demand, targeted drug delivery using magnetic thermosensitive nanocomposites. Presenter: Scott Campbell, McMaster University, CANADA. Author(s): S. B. Campbell, T. R. Hoare. VIEW ABSTRACT

189  Oxygen delivery scaffold for tissue engineering. Presenter: Huaifa Zhang, Faculty of Dentistry, McGill University, CANADA. Author(s): H. Zhang, P. Comeau, F. Tamimi, J. E. Barralet. VIEW ABSTRACT

190  Paclitaxel conjugated polymeric micelle. Presenter: Kihoon Nam, The University of Utah, U.S.A.. Author(s): K. Nam, H. Nam, S. Kim. VIEW ABSTRACT

191  Peptide-linked Targetable Nanoparticles of Tissue Plasminogen Activators for Localized Thrombolysis. Presenter: Shahriar Absar, Texas Tech University Health Sciences Center, U.S.A.. Author(s): S. Absar, F. Ahsan. VIEW ABSTRACT

192  PLGA microsphere/PVA hydrogel coatings for subcutaneous implants: controlling inflammation in a large animal model. Presenter: Michail Kastellorizios, University of Connecticut, U.S.A.. Author(s): M. Kastellorizios, J. Shen, Y. Wang, F. Papadimitrakopoulos, D. Burgess. VIEW ABSTRACT

193  Poly(ortho ester caprolactone): A New Acid-labile Injectable Semi-solid Material for Controlled Drug Delivery. Presenter: Chun Wang, University of Minnesota, U.S.A.. Author(s): W. Wang, C. Wang. VIEW ABSTRACT

194  Polyurethane as a Semi-Permeable Membrane for Controlled Release. Presenter: Alexander Schwarz, Endo Pharmaceuticals Inc., U.S.A.. Author(s): A. Schwarz, S. Thoroughman, D. Winstead. VIEW ABSTRACT

195  Potential of Poly (amidoamine) Dendrimers as ocular carriers of puerarin based on Human Corneal Epithelial Cell Line. Presenter: Kaoxiang Sun, Luye Pharmaceutical Co. Ltd, PRC PEOPLES REP OF CHINA. Author(s): K. Sun. VIEW ABSTRACT

196  Preliminary Characterization of Soft Degradable Biomaterial for Bone Scaffolding Applications. Presenter: Anuja Rane, University Of The Sciences, U.S.A.. Author(s): A. M. Rane, S. Jonnalagadda. VIEW ABSTRACT

197  Preparation and Characterization of Magnolol Loaded Polyketal Microparticles. Presenter: Chen-yu Kao, National Taiwan University of Science and Technology, TAIWAN. Author(s): C. Kao, L. Liu, S. Huang, T. Chou. VIEW ABSTRACT

198  Preparation, Characterization and Drug Release Assessment of Raloxifene Hydrochloride – Carboxylated Polyurethane Nanoparticles. Presenter: Nersi Jafary Omid, Department of pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran, IRAN. Author(s): N. Jafary Omid, N. Babanejad, M. Alavi Nikje, S. Maleki, F. Abedin Dorkoosh. VIEW ABSTRACT

199  Reagentless Bidirectional Lateral Flow Bioactive Paper Sensors for Detection of Pesticides in Beverage and Food Samples. Presenter: Osagie Ayere, NIL, NIGERIA. Author(s): O. C. Ayere. VIEW ABSTRACT

200  Release of Dihydroxyacetone from Poly(carbonate-ester)s Using the Bicinchonic Acid Assay for alpha-Hydroxy Ketone Quantification. Presenter: Jennifer Weiser, Cornell University, U.S.A.. Author(s): J. R. Weiser, A. Yueh, N. G. Ricapito, E. L. Weiser, D. A. Putnam. VIEW ABSTRACT

201  Reverse Thermal Hydrogels based on PPO-PEO-PPO α, ω -Bisphosphate. Presenter: Sang Won Jeong, DGIST, KOREA. Author(s): S. Jeong, S. Kwon, M. Kim, C. Baek, H. Kim, S. Lee, S. Lee, E. Kim. VIEW ABSTRACT

202  Rheological Properties of Commercially Available Viscoelastic Products Useful for Microparticle Suspension. Presenter: Cara Davis, Evonik Industries AG, Pharma Polymers, U.S.A.. Author(s): C. Davis, J. Campbell, A. Raiche. VIEW ABSTRACT

203  Screening for claudin-4 modulators by using a reporter assay system. Presenter: Masuo Kondoh, Osaka University, JAPAN. Author(s): A. Watari, M. Kondoh, K. Yagi. VIEW ABSTRACT

204  Self-healing Kinetics of Microneedle-formed Holes in PLGA Films. Presenter: J. Maxwell Mazzara, University of Michigan, U.S.A.. Author(s): J. Mazzara, S. P. Schwendeman. VIEW ABSTRACT

205  Strategies to tailor protein release from biodegradable hydrophilic multi-block copolymer implants. Presenter: Milica Stankovic, Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, NETHERLANDS. Author(s): M. Stankovic, C. Hiemstra, H. de Waard, W. L. Hinrichs, R. Steendam, H. W. Frijlink. VIEW ABSTRACT

206  Surface functionalization of PLGA nanoparticles with hydrophobic anchored poly(ethylene glycol) co-polymers. Presenter: Morten Ebbesen, Interdisciplinary Nanoscience Center (iNANO), Aarhus University, DENMARK. Author(s): M. Ebbesen, B. Whitehead, B. B. Gonzalez, P. Kingshott, K. A. Howard. VIEW ABSTRACT

207  Target Specific Hyaluronic Acid – Interferon Alpha Conjugate for the Treatment of Hepatitis C Virus Infection. Presenter: Jeong-A Yang, POSTECH, SOUTH KOREA. Author(s): J. Yang, K. Park, H. Kim, S. Hong, S. Yoon, S. Hahn. VIEW ABSTRACT

209  The Influence of Cellulose Acetate Weight Gain and Solvent Ratio on Performance of Push-Pull Osmotic Pump Tablets. Presenter: Hua Deng, Colorcon Inc., U.S.A.. Author(s): H. Deng, L. Martin, S. Missaghi, T. P. Farrell, A. Rajabi-Siahboomi. VIEW ABSTRACT

210  Thermogelling Polypeptide Aqueous Solutions for Protein Drug Delivery and 3D Cell Culture. Presenter: Byeongmoon Jeong, Ewha Womans University, KOREA. Author(s): M. Joo, S. Pramod, H. Moon, M. Park, B. Yeon, B. Jeong. VIEW ABSTRACT

211  Thermoresponsive Block Copolymer-Based Biomaterials for Controlling Cellular Interactions. Presenter: Masamichi Nakayama, Tokyo Women's Medical University, JAPAN. Author(s): M. Nakayama, N. Yamada, J. Akimoto, H. Kanazawa, T. Okano. VIEW ABSTRACT

212  Tunable Growth Factor Delivery from Injectable Hydrogels for Tissue Engineering. Presenter: Katarina Vulic, University of Toronto, CANADA. Author(s): K. Vulic, M. S. Shoichet. VIEW ABSTRACT

213  Tuning size properties in alginate/dextran sulfate particles produced by emulsification. Presenter: Antonio Ribeiro, CEF-Faculdade de Farmacia de Coimbra, PORTUGAL. Author(s): A. J. Ribeiro, J. J. Sousa, D. C. Ferreira, F. J. Veiga. VIEW ABSTRACT

DNA and RNAi Delivery     [RETURN TO TOP]

216  Acid cleavable poly(beta-amino esters) as a pH sensitive gene delivery system. Presenter: Kyeonghye Guk, Chonbuk National Univeristy, KOREA. Author(s): K. Guk, D. Lee, H. Lim, E. Lee, G. Khang. VIEW ABSTRACT

218  Anticancer activity of miR-34a encapsulated into SNALPs or transferrin-conjugated SNALPs. Presenter: Giuseppe De Rosa, University Federico II of Naples, ITALY. Author(s): I. Scognamiglio, M. Di Martino, U. Foresta, A. Virgilio, M. Gallo. Cantafio, P. Tagliaferri, M. Caraglia, A. Galeone, P. Tassone, M. La Rotonda, G. De Rosa. VIEW ABSTRACT

219  Anti-PEG IgM response against PEG-coated liposome is further increased by immune stimulation of siRNA via TLR7. Presenter: Yosuke Hashimoto, Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, The University of Tokushima, JAPAN. Author(s): Y. Hashimoto, T. Ishida, H. Kiwada. VIEW ABSTRACT

220  Biodegradable Polymer Nanoparticles Loaded siRNA/chitosan-g-deoxycholic acid Polyplexes for Prolonged Gene Silencing. Presenter: Jeong Yu Lee, KAIST, SOUTH KOREA. Author(s): J. Lee, S. Lee, M. Oh, J. Kim, Y. Nam. VIEW ABSTRACT

221  Bio-nanocapsule-liposome complex showing excellent in vivo transfection efficiencyin a human hepatic cell-specific manner. Presenter: Kohei Miyabe, Graduate School of Bioagricultural Sciences, Nagoya University, JAPAN. Author(s): K. Miyabe, A. Oeda, M. Yamada, S. Kuroda. VIEW ABSTRACT

222  Bio-reducible Dextran-siRNA Conjugates for Stabilization, Tumor-targeting, and Intracellular Delivery of siRNA. Presenter: Jee Seon Kim, KAIST, SOUTH KOREA. Author(s): J. Kim, M. Oh, J. Park, T. Park, Y. Nam. VIEW ABSTRACT

223  Bio-reducible nanocarrier for therapeutic microRNA delivery to malignant breast cancer. Presenter: In-Kyu Park, Chonnam National University, SOUTH KOREA. Author(s): M. Muthiah, M. Islam, C. Cho, I. Park. VIEW ABSTRACT

224  Bioreducible Polyether-based pDNA Ternary Polyplexes: Balancing Particle Stability and Transfection Efficiency. Presenter: Tsz Chung Lai, University of Wisconsin-Madison, U.S.A.. Author(s): T. Lai, K. Kataoka, G. S. Kwon. VIEW ABSTRACT

225  Calcium phosphate nanocapsule as durable gene delivery system for plasmid DNA complex. Presenter: Tomoko Ito, Musashino University, Research Institute of Pharmaceutical Sciences, JAPAN. Author(s): T. Ito, M. Otsuka, Y. Koyama. VIEW ABSTRACT

226  Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. Presenter: Kazuo Maruyama, Teikyo University, JAPAN. Author(s): K. Maruyama, Y. Oda, K. Hirata, T. Nomura, N. Utoguchi, R. Suzuki. VIEW ABSTRACT

228  Choline Kinase Targeted siRNA in PEGylated Liposome for Breast Cancer Therapy. Presenter: Jae-Yeon Shim, Research Center for Cell Fate Control and College of Pharmacy, Sookmyung Women's University, KOREA. Author(s): J. Shim, J. Kim, J. Kim. VIEW ABSTRACT

229  Co-delivery of siRNA and Doxorubicin into Cancer Cells by Cationic Liposomes based on pH-Sensitive Polymers. Presenter: Jeong-Sook Park, Chungnam National University, KOREA. Author(s): D. Yeo, E. Davaa, U. Jeong, V. K. Garripelli, S. Jo, J. Kim, J. Park. VIEW ABSTRACT

230  Computational Pharmaceutics - the Application of Molecular Modeling in Drug Delivery. Presenter: Defang Ouyang, School of Life & Health Sciences, Aston University, Birmingham, B4 7ET, UNITED KINGDOM. Author(s): D. Ouyang. VIEW ABSTRACT

231  Confirming RNAi-mediated Gene Silencing in tumor by PEGylated siRNA-loaded liposome with pH-sensitive cationic lipid. Presenter: Yu Sakurai, Hokkaido University, JAPAN. Author(s): Y. Sakurai, H. Hatakeyama, Y. Sato, M. Hyodo, H. Akita, H. Harashima. VIEW ABSTRACT

232  Controllable Release of Smart Polymer Nano-micelles for siRNA Delivery from Injectable Polyurethane Scaffolds In Vivo. Presenter: Craig Duvall, Vanderbilt University, U.S.A.. Author(s): C. E. Nelson, E. J. Adolph, M. K. Gupta, F. Yu, J. M. Davidson, S. A. Guelcher, C. L. Duvall. VIEW ABSTRACT

233  Controlled release of BMP-2 to Mesenchymal Stem Cell for bone regeneration. Presenter: Hyejin Chung, Ewha Womans University, KOREA. Author(s): H. Chung, S. Lee, J. Doo, J. Shin. VIEW ABSTRACT

234  Controlled shielding & deshielding of HES-decorated polyplexes using alpha amylase. Presenter: Matthäus Noga, Pharmaceutical Technology and Biopharmaceutics, Department of Pharnacy, LMU Munich, GERMANY. Author(s): M. Noga, D. Edinger, E. Wagner, G. Winter, A. Besheer. VIEW ABSTRACT

235  Delivery of siRNA by PEG-alendronate-stabilized calcium phosphate nanoparticles. Presenter: Elisabeth Giger, ETH Zurich, SWITZERLAND. Author(s): E. V. Giger, B. Castagner, J. Leroux. VIEW ABSTRACT

236  Delivery of siRNA to Cancer Cells Using Interleukin-4 Receptor Targeted Peptide-Conjugated BPEI-SPION Nanoparticle Complex. Presenter: Guruprasath Padmanaban, Department of Biochemistry and Cell Biology, School of Medicine, Kyungpook National University, SOUTH KOREA. Author(s): G. Padmanaban, N. Ran, K. Won. Jong, P. In. Kyu, K. In. San, L. Byung-Heon. VIEW ABSTRACT

237  Design and evaluation of surface modified, poly (beta amino ester) containing nanoparticles for plasmid DNA delivery. Presenter: Rachel Fields, Yale University, U.S.A.. Author(s): R. J. Fields, C. Cheng, E. Quijano, C. Weller, N. Duong, N. Kristofik, M. Egan, M. Saltzman. VIEW ABSTRACT

238  Development of RAGE siRNA delivery system using bile acid-modified PEI for the treatment of myocardial infarction. Presenter: Ju-yeon Lee, Severance Hospital Integrative Research Institute for Cerebral & Cardiovascular Diseases Yonsei University Health System , SOUTH KOREA. Author(s): S. Kim, J. Lee. VIEW ABSTRACT

239  Development of redox-sensitive, core-crosslinked, hTERT siRNA loaded polyethylene glycol grafted polyethyleneimine nanoparticles. Presenter: Samira Abolmaali, Department of Pharmaceutics, Shiraz Faculty of Pharmacy, IRAN. Author(s): S. S. Abolmaali, F. Safari, A. M. Tamaddon. VIEW ABSTRACT

240  Dimeric siRNA Conjugates with Different Spacer Lengths for Efficient Intracellular Delivery and Gene Silencing. Presenter: Sung Duk Jo, Departmen of Biological Sciences, KAIST, SOUTH KOREA. Author(s): S. Jo, H. Mok, Y. Nam. VIEW ABSTRACT

241  Disulfide Reduction Considerations for Cationic Gene Delivery Systems. Presenter: Lorine Brülisauer, ETH Zürich, Department of Chemistry and Applied Biosciences, Institute of Pharmaceutical Sciences, SWITZERLAND. Author(s): L. Brülisauer, M. A. Gauthier, J. Leroux. VIEW ABSTRACT

244  Efficient gene delivery using dendrimer type bioreducible polymer. Presenter: Hye Yeong Nam, University Of Utah, U.S.A.. Author(s): H. Nam. VIEW ABSTRACT

245  Efficient protection and increased gastrointestinal deposition of siRNA after oral administration of siRNA/chitosan nanoparticles. Presenter: Borja Ballarín-González, Aarhus University, SPAIN. Author(s): B. Ballarín-González, F. Dagnaes-Hansen, S. Gao, S. Hein, J. Kjems, K. A. Howard. VIEW ABSTRACT

246  Elucidation of Morphology and in vitro Activity of Anionic siRNA Lipoplexes: Biophysical Characterization Studies. Presenter: Mamta Kapoor, Department of Pharmaceutical Sciences, University of Connecticut, U.S.A.. Author(s): M. Kapoor, D. J. Burgess. VIEW ABSTRACT

247  Enhanced Gene Transfection using Calcium Phosphate Co-precipitates and Low-Intensity Pulsed Ultrasound. Presenter: Iman Ahmed, University of Sharjah, UAE. Author(s): I. S. Ahmed, M. A. Hassan, P. Campbell, T. Kondo. VIEW ABSTRACT

249  Evaluation of carrier-mediated siRNA delivery: A novel stem-loop qPCR-based approach for intracellular full-length siRNA quantification. Presenter: Stefano Colombo, Department of Pharmaceutics and Analytical Chemistry, Faculty of Health and Medical Sciences, Copenhagen University., DENMARK. Author(s): S. Colombo, H. Mørck. Nielsen, C. Foged. VIEW ABSTRACT

250  Gene therapy for LPS/D-GalN-induced hepatitis by octaarginine peptide-modified nanoparticles. Presenter: Ryoichi Mizuno, Laboratory for Molecular Design of Pharmaceutics, Faculty of Pharmaceutical Sciences, Hokkaido University, Sapporo, Hokkaido, JAPAN. Author(s): R. Mizuno, Y. Hayashi, K. A. Ikramy, H. Akita, H. Harashima. VIEW ABSTRACT

251  Grapheme oxide(GO)-Polyethylenimine (PEI) conjugate as a gene delivery carrier and imaging agent. Presenter: Won Jong Kim, POSTECH, SOUTH KOREA. Author(s): H. Kim, R. Namgung, W. Kim. VIEW ABSTRACT

252  High Transfection Efficiency by Polymannitol-based Transporter through Caveolae-mediated Endocytosis pathway. Presenter: Chong-su Cho, Department of Agricultural Biotechnology and Research Institute for Agriculture and Life Sciences, Seoul National University, KOREA. Author(s): C. Cho. VIEW ABSTRACT

253  Hydrogel for Enhanced Intravesical Delivery of Lentiviral Vector Expressing WWOX in vivo. Presenter: Li-Ching Chang, Department of Occupational Therapy, I-Shou University, TAIWAN. Author(s): C. Liu, T. Tsai, S. Fan, Nien, L. Chang. VIEW ABSTRACT

254  In vitro Silencing Activity of Amphiphilic Antisense Oligonucleotides. Presenter: Arnaud Felber, ETHZ, SWITZERLAND. Author(s): A. E. Felber, N. Bayó-Puxan, B. Castagner, G. F. Deleavey, M. J. Damha, J. Leroux. VIEW ABSTRACT

255  In vitro/in vivo correlation analysis using siRNA-loaded lipid nanoparticles. Presenter: Yuki Noguchi, Laboratory for Molecular Design of Phamaceutics, Faculty of Phamaceutical Sciences, Hokkaido University, JAPAN. Author(s): Y. Noguchi, Y. Hayashi, H. Harashima. VIEW ABSTRACT

257  Injectable Polyplex Hydrogel for Localized and Long-term Delivery of siRNA. Presenter: Young-Min Kim, Center for Biomaterials, Korea Institute of Science and Technology, KOREA. Author(s): Y. Kim, M. Park, C. Chun, S. Song. VIEW ABSTRACT

258  Injectable Thermo-responsive Hydrogel Containing LDH Nanoparticles Mediating siRNA Delivery into Chondrocytes. Presenter: Hsiao-yin Yang, University Medical Center Utrecht, NETHERLANDS. Author(s): H. Yang, R. J. van Ee, N. E. Papen-Botterhuis, C. Oner, W. J. Dhert, L. B. Creemers. VIEW ABSTRACT

259  Knockdown of Survivin Protein Expression Using Liposomal siRNA. Presenter: Sudip Das, Butler University, U.S.A.. Author(s): S. K. Das, R. M. Kagdi, N. G. Das. VIEW ABSTRACT

260  LinOS/cholesterol - a non-toxic vector for the delivery of siRNA effecting quantitative silencing of EGFP in HeLa cells. Presenter: Ian Blagbrough, University of Bath, UNITED KINGDOM. Author(s): A. A. Metwally, I. S. Blagbrough. VIEW ABSTRACT

261  Lipid Nanoparticles for Inhalation Co-Delivery of Anticancer Drug and siRNA. Presenter: Andriy Kuzmov, Rutgers, The State University of New Jersey, U.S.A.. Author(s): A. Kuzmov, O. Taratula, O. B. Garbuzenko, M. Shah, V. Shah, T. Minko. VIEW ABSTRACT

262  Mixed Carrier Made of Phospholipid-modified PEI and PEG-PE Improves Systemic Delivery of siRNA in tumors. Presenter: Sean Essex, Northeastern University, Pharmaceutical Sciences and Center for Pharmaceutical Biotechnology and Nanomedicine, U.S.A.. Author(s): S. Essex. , G. Navarro, A. Chordia, V. Torchilin. VIEW ABSTRACT

263  MMP-Responsive, Proximity-activated Targeting Polymeric Nanoparticles for siRNA Delivery. Presenter: Craig Duvall, Vanderbilt University, U.S.A.. Author(s): C. L. Duvall, H. Li, T. D. Giorgio, S. S. Yu, M. Miteva, C. E. Nelson. VIEW ABSTRACT

264  Modification of Dendrimers for Enhanced SiRNA Delivery. Presenter: Swati Biswas, Northeastern University, U.S.A.. Author(s): S. Biswas, G. Navarro, N. S. Dodwadkar, P. P. Deshpande, V. P. Torchilin. VIEW ABSTRACT

265  Mutually Cross-linked siRNA/LPEI Nanogels for Efficient Gene Silencing. Presenter: Cheol Am Hong, Korea Advanced Institute of Science and Technology (KAIST), SOUTH KOREA. Author(s): C. Hong, J. Kim, H. Mok, Y. Nam. VIEW ABSTRACT

266  Myocardial Ischemia Gene Therapy Using Post-translational Regulated and Hypoxia-responsible VEGF Plasmid. Presenter: Young-Wook Won, Center for Controlled Chemical Delivery (CCCD), Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, Utah, U.S.A.. Author(s): Y. Won, M. Lee, S. Kim. VIEW ABSTRACT

267  Natural alveolar surfactant potentiates intracellular siRNA delivery by dextran nanogels. Presenter: Lynn De Backer, Ghent Research Group on Nanomedicines, Laboratory of General Biochemistry and Physical Pharmacy, Ghent University, BELGIUM. Author(s): L. De Backer, K. Braeckmans, J. Demeester, S. De Smedt, K. Raemdonck. VIEW ABSTRACT

268  New pH Responsive Nanovesicular Vectors For Tumor Targeting. Presenter: Stefano Salmaso, Department of Pharmaceutical Sciences, University of Padua, ITALY. Author(s): E. Gallon, S. Salmaso, F. Mastrotto, S. Bersani, J. Sanchis, M. J. Vicent, G. Mantovani, T. Matini, C. Alexander, P. Caliceti. VIEW ABSTRACT

269  Novel pH-sensitive carbonate apatite nanoparticles as intracellular Gene/Drug transporter. Presenter: Sharif Hossain, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama-shi, JAPAN. Author(s): S. Hossain. VIEW ABSTRACT

270  Optimizing chitosan for siRNA delivery and P-gp silencing in rat brain endothelial cells. Presenter: Jostein Malmo, Department of Biotechnology, Norwegian Biopolymer Laboratory (NOBIPOL), Norwegian University of Science and Technology (NTNU), NORWAY. Author(s): J. Malmo, H. Sørgård, A. Sandvig, K. M. Vårum, S. P. Strand. VIEW ABSTRACT

272  PEGylated Solid Lipid Nanoparticles: A Promising Carrier for siRNA delivery to Carcinoma Cells. Presenter: Diana Rafael, Research Institute for Medicines and Pharmaceutical Sciences (iMed.UL), PORTUGAL. Author(s): D. Rafael. VIEW ABSTRACT

274  pH-responsive lipids based on a molecular switchfor the improved delivery of nucleic acids. Presenter: Jeanne Leblond Chain, University of Montreal, CANADA. Author(s): J. Leblond. Chain. VIEW ABSTRACT

275  Polymeric micelle-based antioxdative transfection system for highly enhanced gene transfection. Presenter: Min Sang Lee, Sungkyunkwan University, KOREA. Author(s): M. Lee, J. Jeong. VIEW ABSTRACT

276  Preparation of pH-responsive polymers for delivery of nucleic acids. Presenter: Teresa Matini, The University of Nottingham, UNITED KINGDOM. Author(s): T. Matini, C. Alexander, G. Mantovani, S. Spain, E. Gallon, F. Mastrotto, P. Caliceti, S. Salmaso, J. Sanchis, M. J. Vicent. VIEW ABSTRACT

277  Protein-Polymer Core-Shell Conjugates for Controlled siRNA Delivery. Presenter: Martin Nussbaumer, University of Basel, SWITZERLAND. Author(s): M. G. Nussbaumer. VIEW ABSTRACT

278  siRNA Delivery into a Breast Orthotopic Xenograft Using a Tumor-Targeted Polymeric Nanoparticle (PNP) Following Systemic Administration. Presenter: Christian Peters, Cerulean Pharma, U.S.A.. Author(s): C. G. Peters, J. Hwang, P. Lim. Soo, R. I. Case, R. O. Cole, P. Shum, B. Sweryda-Krawiec, S. Kabir, S. Svenson, S. Eliasof, D. Lazarus. VIEW ABSTRACT

279  Smart cytoplasm-responsive nanocarriers conjugated with a functional peptide for treating cancer by systemic siRNA delivery. Presenter: Hiroaki Okada, Okada DDS Research Institute, Inc., JAPAN. Author(s): K. Tanaka, T. Kanazawa, K. Sugawara, S. Horiuchi, Y. Takashima, H. Okada. VIEW ABSTRACT

281  Structure-dependent Lysosomal Transit of Chitosan-pDNA Polyplexes. Presenter: Marc Thibault, Ecole Polytechnique, CANADA. Author(s): M. Thibault, M. Astolfi, I. Richard, M. Lavertu, M. D. Buschmann. VIEW ABSTRACT

282  Studying bPEI:DNA-polyplex properties and cell interactions with label-free surface sensitive physicochemical techniques. Presenter: Tapani Viitala, Division of Biopharmaceutics and Pharmacokinetics, University of Helsinki, FINLAND. Author(s): T. Viitala, M. Hanzlikova, T. Silen, P. Ilina, F. M. Winnik, A. Urtti, M. Yliperttula. VIEW ABSTRACT

283  Suppression of tumor growth by systemic delivery of anti-VEGF siRNA with cell-penetrating peptide-modified MPEG-PCL nanomicelles. Presenter: Takanori Kanazawa, Tokyo University of Pharmacy and Life Sciences, JAPAN. Author(s): T. Kanazawa, K. Sugawara, K. Tanaka, S. Horiuchi, Y. Takashima, H. Okada, Y. Seta. VIEW ABSTRACT

284  Surface Modified Polymer Nanoparticles for Enhanced Delivery of Microbicidal siRNAs. Presenter: Jill Steinbach, Yale University, U.S.A.. Author(s): J. M. Steinbach, W. Saltzman. VIEW ABSTRACT

286  Targeted Polymeric Gene Carriers to Deliver a Therapeutic sRAE-1 Plasmid to the Pancreatic Islets for the Prevention of Type 1 Diabetes. Presenter: Wanseok Joo, Center for Controlled Chemical Delivery, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, U.S.A.. Author(s): W. Joo, K. Nam, J. Jeong, K. S. Blevins, S. Kim. VIEW ABSTRACT

287  The Development of Rath cell penetrating peptide-dendrimer Gene Delivery Systems. Presenter: Jung-hua Kuo, Chia Nan University of Pharmacy and Science, TAIWAN. Author(s): J. S. Kuo, C. Lin. VIEW ABSTRACT

288  The Synthesis of Monodisperse, Reducible Nucleic Acid Delivery Polypeptides. Presenter: Mark Ericson, Division of Medicinal and Natural Products Chemistry, College of Pharmacy, The University of Iowa, U.S.A.. Author(s): M. D. Ericson, K. G. Rice. VIEW ABSTRACT

289  Therapeutic Silencing of Akt1 gene expression mediated by surface-immobilized Akt siRNA/ssPEI nanoparticles on coronary stent for Alleviating post-angioplasty restenosis. Presenter: In Kyu Park, Chonnam National University, SOUTH KOREA. Author(s): H. Che, I. Bae, H. Lee, W. Kim, Y. Ahn, I. Park. VIEW ABSTRACT

290  Transferrin-targeted Phospholipid-modified PEI-based Micellar Nanocarriers for Dual Delivery of siRNA and Anticancer Drugs. Presenter: Gemma Navarro, Northeastern University, U.S.A.. Author(s): G. Navarro, R. Sawant, S. Biswas, S. Essex, C. Tros de ILarduya, V. P. Torchilin. VIEW ABSTRACT

709  Investigating the depot-formation of cationic liposome-based DNA vaccines. Presenter: B. Moghaddam, Aston University, UNITED KINGDOM. Author(s): B. Moghaddam, Q. Zheng, Y. Perrie. VIEW ABSTRACT

Drug Delivery to the Brain     [RETURN TO TOP]

291  A PET based method for real time monitoring of drug concentration in the liquid phase of the leptomeningeal compartment.. Presenter: Vasily Belov, Massachusetts General Hospital, U.S.A.. Author(s): V. Belov, M. Papisov. VIEW ABSTRACT

292  Brain uptake of a fluorescent vector targeting the transferrin receptor: a novel application of in situ brain perfusion. Presenter: Wael Alata, Centre Hospitalier de l’Université Laval Research Center, CANADA. Author(s): W. Alata, V. Emond, F. Calon. VIEW ABSTRACT

293  Controlled Delivery of Cyclosporin A to the Stroke-Injured Brain. Presenter: Matthew Caicco, University of Toronto, CANADA. Author(s): M. J. Caicco, M. J. Cooke, Y. Wang, A. Tuladhar, C. M. Morshead, M. S. Shoichet. VIEW ABSTRACT

294  Convection-Enhanced Delivery of Surface-Modified Brain-Penetrating Nanoparticles in Glioma. Presenter: Jennifer Saucier-Sawyer, Yale University, U.S.A.. Author(s): J. K. Saucier-Sawyer, A. J. Sawyer, C. J. Cheng, J. Zhou, W. Saltzman. VIEW ABSTRACT

296  Glutathione PEGylated Liposomes to Safely Enhance the Delivery of Drugs to the Brain. Presenter: Jaap Rip, to-BBB technologies BV, NETHERLANDS. Author(s): J. Rip. , A. Borgs, C. C. Appeldoorn, J. van Kregten, L. Chen, M. Hammarlund-Udenaes, P. J. Gaillard. VIEW ABSTRACT

297  In vivo administration of VEGF and GDNF releasing biodegradable microspheres in a severe lesion model of Parkinson’s disease. Presenter: Manoli Igartua, NanoBioCel Group, Laboratory of Pharmaceutics, University of the Basque Country (UPV/EHU), School of Pharmacy, Vitoria, Spain, SPAIN. Author(s): E. Herrán, J. Ruiz-Ortega, A. Aristieta, M. Igartua, C. Requejo, J. Lafuente, L. Ugedo, J. Pedraz, R. M. Hernández. VIEW ABSTRACT

298  In Vivo Internalization of Monoclonal Antibody Targeting the Murin Transferrin Receptor by Brain Capillary Endothelial Cells. Presenter: Sarah Paris-Robidas, Faculty of Pharmacy Laval University, Quebec city, QC, Canada; CHUQ Research Center, Quebec city, QC, CANADA. Author(s): S. Paris-Robidas, M. Laplante, M. Champigny, V. Emond, M. Parent. VIEW ABSTRACT

300  Parenteral Microemulsion of Curcumin for Brain Targeting. Presenter: Rajshree Shinde, Institute of Chemical Technolgy, INDIA. Author(s): R. L. Shinde, P. V. Devarajan. VIEW ABSTRACT

301  The effect of Fe3O4 nanoparticle-induced hyperthermia on the blood brain-barrier association and permeability. Presenter: Mo Dan, University of Kentucky, U.S.A.. Author(s): M. Dan, Y. Bae, T. D. Dziubla, D. F. Scott, J. Hilt, R. A. Yokel. VIEW ABSTRACT

302  Zolimitriptan Transbuccal Delivery by a Dissolving Microneedle Patch. Presenter: Sung-Yun Kwon, TheraJect, Inc., U.S.A.. Author(s): S. Kwon. VIEW ABSTRACT

Inorganic Nanosystems     [RETURN TO TOP]

305  Novel Technology for Taste Masking : Applied to Sildenafil Citrate. Presenter: Sanghan Park, Daewoong Life Science Research Institute, SOUTH KOREA. Author(s): H. Chang, B. Kang, K. Lee, S. Park. VIEW ABSTRACT

306  Polymeric and non-polymeric magnetic nanoparticle uptake and gene delivery to endothelial cells. Presenter: Jillian Tengood, Children's Hospital of Philadelphia, U.S.A.. Author(s): J. Tengood, I. Alferiev, I. Fishbein, R. J. Levy, M. Chorny. VIEW ABSTRACT

Intracellular Processes     [RETURN TO TOP]

307  Doxil ® Modification with Octa-Arginine Conjugated Polymer for Enhanced Anticancer Activity. Presenter: Swati Biswas, Northeastern University, U.S.A.. Author(s): S. Biswas, N. S. Dodwadkar, P. P. Deshpande, V. P. Torchilin. VIEW ABSTRACT

308  Elucidating uptake and intracellular trafficking of Polyrotaxane-siRNA nanoplexes. Presenter: Prajakta Dandekar-Jain, Nanomedicine Lab, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology (ICT), Matunga, Mumbai 400019, INDIA. Author(s): P. Dandekar-Jain, R. Jain, B. Loretz, M. Keil, M. Schneider, G. Wenz, C. Lehr. VIEW ABSTRACT

309  Exploring the cell penetrating ability, membrane activity and proapoptotic activity of Tat derived multifunctional peptide, Tat-LK15. Presenter: Myasar AL-kotaji, School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, M13 9PT, UK, UNITED KINGDOM. Author(s): M. AL-kotaji, A. Pluen. VIEW ABSTRACT

310  ICAM-1-Targeted Nanocarriers are Endocytosed in the Gastrointestinal Tract of Mice. Presenter: Viraj Mane, Institute for Bioscience and Biotechnology Research, University of Maryland, U.S.A.. Author(s): V. P. Mane, R. Ghaffarian, S. Muro. VIEW ABSTRACT

311  In Vivo Performance of Nanocarriers Dually-Targeted to Epitopes of the Same Versus Different Receptors. Presenter: Jason Papademetriou, Fischell department of Bioengineering, University of Maryland-College Park, U.S.A.. Author(s): J. T. Papademetriou, C. Garnacho, S. Muro-Galindo. VIEW ABSTRACT

312  Interaction of gold nanoparticles with neural cells. Presenter: Sebastien Boridy, Department of Pharmacology and Therapeutics, McGill University, Montreal, Qc, CANADA. Author(s): S. Boridy, E. Hutter, D. Maysinger. VIEW ABSTRACT

313  Mitochondrial delivery of bioactive molecules using Dual Function (DF)-MITO-Porter aimed at the mitochondrial genome. Presenter: Yuma Yamada, Faculty of Pharmaceutical Sciences, Hokkaido University, JAPAN. Author(s): Y. Yamada, H. Harashima. VIEW ABSTRACT

314  New insight of microbubbles-cell interactions during sonoporation process. Presenter: Lucie Pigeon, Centre de Biophysique Moléculaire UPR 4301 CNRS, FRANCE. Author(s): L. Pigeon, A. Delalande, S. Kotopoulis, M. Postema, P. Midoux, C. Pichon. VIEW ABSTRACT

315  Nuclear Targeted Delivery of Bleomycin by Octaarginine-modified Fusogenic Liposomes for Cancer Treatment.. Presenter: Alexander Koshkaryev, Northeastern University, U.S.A.. Author(s): A. Koshkaryev, A. Piroyan, V. P. Torchilin. VIEW ABSTRACT

316  Silica Nanoparticle Surface Orientation Dictates the Mechanism of Uptake. Presenter: Heather Herd, University of Utah, U.S.A.. Author(s): H. Herd, N. Daum, C. Lehr, H. Ghandehari. VIEW ABSTRACT

Nanomedicines     [RETURN TO TOP]

317  'Smart' Micelles for Reactive Oxygen Species Triggered Drug Release. Presenter: Craig Duvall, Department of Biomedical Engineering, Vanderbilt University, U.S.A.. Author(s): M. K. Gupta, T. A. Meyer, C. E. Nelson, C. L. Duvall. VIEW ABSTRACT

318  3-in-1 Polymeric Micelles for Ovarian Cancer Treatment. Presenter: Hyunah Cho, University of Wisconsin-Madison, U.S.A.. Author(s): H. Cho, G. Kwon. VIEW ABSTRACT

319  A Novel Method for the Manufacture of Protein-Coated Nanoparticles. Presenter: Javier Morales, College of Pharmacy at The University of Texas at Austin, U.S.A.. Author(s): J. O. Morales, G. M. Joks, A. Lamprecht, A. C. Ross, J. T. McConville. VIEW ABSTRACT

321  A Novel Triblock Copolymer for Combination Delivery of siRNA/Drug. Presenter: San Zeng, University of Wisconsin Madison, U.S.A.. Author(s): S. Zeng, M. P. Xiong. VIEW ABSTRACT

322  A thermosensitive liposome prepared with a Cu2+ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy. Presenter: Jonathan May, Ontario Institute of Cancer Research, CANADA. Author(s): J. P. May, M. J. Ernsting, S. Li. VIEW ABSTRACT

323  Advanced Spray Dried Microparticulate/Nanoparticulate Inhalable Polymeric Lipospheres Containing Paclitaxel for Targeted Pulmonary Nanomedicine in Lung Cancer Treatment. Presenter: Samantha Meenach, University of Kentucky, U.S.A.. Author(s): S. A. Meenach, R. C. McGarry, J. Z. Hilt, K. W. Anderson, H. M. Mansour. VIEW ABSTRACT

324  Amphotericin B loaded glycerol monooleate nanoparticle: Enhanced in vivo bioavailability with reduced toxicity an implication for fungal therapy. Presenter: Chandana Mohanty, Institute of Life Science, INDIA. Author(s): C. Mohanty. VIEW ABSTRACT

325  Apoptotic mechanisms of arsonoliposomes on medulloblastoma cell lines in normoxic and hypoxic conditions. Presenter: Marco Emanuele Favretto, NCMLS, Radboud Medical Centre, Radboud University, Nijmegen, NETHERLANDS. Author(s): M. Favretto, P. V. Ioannu, B. F. Gibbs, T. L. Parker, P. Kallinteri. VIEW ABSTRACT

326  Backbone degradable HPMA Copolymer-Gemcitabine Conjugates for the treatment of Ovarian Cancer. Presenter: Jiyuan Yang, University of Utah, U.S.A.. Author(s): J. J. Yang, H. Pan, K. Luo, P. Kopecekova, J. Kopecek. VIEW ABSTRACT

327  Biodegradable and Injectable Poly(organophosphazene)-Camptothecin Conjugate Hydrogel: Physicochemical Properties and Antitumor Activity. Presenter: Jung-Kyo Cho, Korea Institute of Science and Technology, SOUTH KOREA. Author(s): J. Cho, C. Chun, H. Kuh, S. Song. VIEW ABSTRACT

329  Cancer cell targeted self-quenching pullulan/folate-photosensitizer conjugates for photodynamic therapy. Presenter: Byoung-chan Bae, Department of Biotechnology, The Catholic University of Korea, SOUTH KOREA. Author(s): B. Bae, K. Na. VIEW ABSTRACT

331  Cellax, a docetaxel-carboxymethylcellulose nanoparticle, exhibits enhanced pharmacokinetic, biodistribution and metastatic cancer treatment efficacy profiles compared to Taxotere. Presenter: Mark Ernsting, Ontario Institute for Cancer Research, CANADA. Author(s): M. J. Ernsting, E. Undzys, M. Murakami, S. Li. VIEW ABSTRACT

332  Co-delivery of Bupivacaine-HCl and pH-modulating Agents through Micro-fluidic Channels for Enhanced Control of Drug Release. Presenter: SungYeun Yang, Yonsei University, SOUTH KOREA. Author(s): S. Yang, K. Lee, W. Ryu. VIEW ABSTRACT

334  Core crosslinked Pluronic micelles conjugated with doxorubicin and folic acid for cancer chemotherapy. Presenter: Dai Hai Nguyen, Department of Molecular Science and Technology, Ajou University, KOREA. Author(s): D. Nguyen, J. Bae, J. Choi, K. Park. VIEW ABSTRACT

335  Cryo Transmission Electron Microscopy as an Orthogonal Tool for Characterization of Nanoparticle Drug Delivery Systems. Presenter: Anke Mulder, NanoImaging Services Inc., U.S.A.. Author(s): A. M. Mulder, B. Carragher, C. potter. VIEW ABSTRACT

336  Cyclopamine and Gefitinib Loaded Micelles for Combination Chemotherapy of Pancreatic Cancer. Presenter: Deepak Chitkara, University of Tennessee Health Science Center, U.S.A.. Author(s): D. Chitkara, S. Singh, V. Kumar, N. Kumar, S. W. Behrman, R. I. Mahato. VIEW ABSTRACT

337  Dectin-1 Mediated Delivery System Anti-Inflammatory Drug and Photo-Sensitizer to Immune Cells. Presenter: Yuta Kagoshima, Osaka City University, JAPAN. Author(s): Y. Kagoshima. VIEW ABSTRACT

338  Dendrimer Nanocarriers For Transport Modulation Across the Airway Epithelium. Presenter: Sandro da Rocha, Wayne State University, U.S.A.. Author(s): B. Bharatwaj, R. Dimovsku, D. Conti, S. da. Rocha. VIEW ABSTRACT

340  Design and Evaluation of Combination Polymeric Nanoparticles of Doxycycline and Rifampicin. Presenter: Shilpa Dawre, Institute of Chemical Technology, INDIA. Author(s): S. Dawre, R. V. Gaikwad, A. Samad, P. V. Devarajan. VIEW ABSTRACT

341  Design and Evaluation of Folic acid Conjugated Docetaxel Loaded Nanoparticles. Presenter: Shilpa Pawar, C.U.Shah College of Pharmacy, INDIA. Author(s): K. K. Singh, S. B. Pawar, N. P. Saini. VIEW ABSTRACT

342  Determination of surface hydrophobicity of cationic solid lipid nanoparticles. Presenter: Rainer Muller, Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics & NutriCosmetics, Freie Universität Berlin, Berlin, Germany, GERMANY. Author(s): S. Doktorovova, R. Shegokar, P. Martins-Lopes, A. M. Silva, R. H. Muller, E. B. Souto. VIEW ABSTRACT

344  Development of Biodegradable Microneedle Cuff for Vascular Diseases. Presenter: Chang Kuk Choi, School of Mechanical Engineering, Yonsei University, KOREA. Author(s): C. Choi, J. Kim, S. Park, E. Jang, Y. Youn, W. Ryu. VIEW ABSTRACT

345  Development of Buparvaquone Solid Lipid Nanoparticles by Green Technology. Presenter: Maheshkumar Soni, Institute of Chemical Technology, INDIA. Author(s): M. P. Soni, S. Londhe, G. Vanage, R. Gaikvad, A. Samad, P. Devarajan. VIEW ABSTRACT

346  Development of Nano-sized Polyion Complex Vesicles 'PICsomes' as a Tool for Investigation of in vivo Nano-environment. Presenter: Akihiro Kishimura, Graduate School of Engineering, The University of Tokyo, JAPAN. Author(s): A. Kishimura, Y. Anraku, K. Kataoka. VIEW ABSTRACT

347  Development of Polyion Complex Vesicles 'PICsomes' toward a Versatile Platform for Delivery of Biomacromolecules and Nano-materials. Presenter: Akihiro Kishimura, Graduate School of Engineering, The University of Tokyo, JAPAN. Author(s): A. Kishimura, Y. Anraku, S. Chuanoi, K. Miyata, D. Kokuryo, I. Aoki, T. Saga, K. Kataoka. VIEW ABSTRACT

348  Diethylene Glycol (DEG) Functionalized Self-Assembling Peptides as Potential Nanocarriers for Hydrophobic Anticancer Drug Delivery. Presenter: Parisa Sadatmousavi, PhD Candidate, Waterloo Institute of Nanotechnology, Department of Chemical Engineering , CANADA. Author(s): P. Sadatmousavi, P. Chen. VIEW ABSTRACT

349  Doxorubicin and mitomycin co-loaded polymer lipid hybrid nanoparticle system increases efficacy against human breast cancer tumor in vivo. Presenter: Preethy Prasad, Department of Pharmaceutical Sciences, Leslie Dan Faculty of Pharmacy, University of Toronto, 144 College Street, Toronto, Ontario, CANADA. Author(s): P. Prasad, P. Cai, A. Shuhendler, A. Rauth, X. Wu. VIEW ABSTRACT

350  Effect of Elastic Liposomes and Block Co-polymer coated Elastic Liposomes in the VEGF-expression and Ocular Pharmacokinetics of Bevacizumab after Intravitreal injection.. Presenter: Cristina Bruno, Universidade Federal of Espírito Santo, BRAZIL. Author(s): C. Bruno, J. A. Cardillo, A. A. Lima, A. G. Oliveira. VIEW ABSTRACT

351  Effect of particle size on endocytic uptake by alveolar macrophage cells. Presenter: Keiji Hirota, Faculty of Pharmaceutical Sciences, Tokyo University of Science, JAPAN. Author(s): K. Hirota, S. Shirai, S. Kimura, H. Terada. VIEW ABSTRACT

352  Efficient overcoming of doxorubicin resistance in MCF-7/ADR cell line by substituting tariquidar with curcumin in nanoformulations for cancer therapy. Presenter: Ranjita Misra, Institute of Life Sciences, INDIA. Author(s): R. Misra. VIEW ABSTRACT

353  Encapsulation of Amphotericin B into PEG-grafted-PLA Nanoparticles: Characterization and Anti Fungal Efficacy. Presenter: Valery Aoun, Université de Montréal, CANADA. Author(s): V. Aoun, P. LePape, P. Hildgen, G. Leclair. VIEW ABSTRACT

354  Engineer Drug Nanocrystals to Overcome the Mucus Barrier for Mucosal Delivery. Presenter: Tao Yu, Johns Hopkins School of Medicine, Johns Hopkins University, U.S.A.. Author(s): T. Yu, W. Choi, S. Pulicare, W. Zhong, M. Chen, S. K. Lai, J. Hanes. VIEW ABSTRACT

355  Engineering of Doxorubicin Gold Nanoparticles Using Folate Anchored Pegylated Poly(aspartic acid). Presenter: Sameera Khandekar, Institute of Chemical Technology and National Chemical Laboratory (CSIR), INDIA. Author(s): S. V. Khandekar, M. G. Kulkarni, P. V. Devarajan. VIEW ABSTRACT

357  Epirubicin Nanoemulsion Enhanced Intravesical Permeability and Reduced Bladder Irritation. Presenter: Li-Ching Chang, Department of Occupational Therapy, I-Shou University, TAIWAN. Author(s): L. Chang, C. Liu, P. Li, L. Lin, T. Tsai. VIEW ABSTRACT

358  Epithelial Active Targeting By Lectin-Nanoparticles In Murine Experimental Colitis. Presenter: Moulari Brice, University of Franche-Comté, FRANCE. Author(s): M. Brice, B. Arnaud, P. Yann, L. Alf. VIEW ABSTRACT

359  Evaluation and Characterization of Milrinone-loaded PEG-grafted-PLA Nanoparticles Intended for Pulmonary Delivery. Presenter: Valery Aoun, Université de Montréal, CANADA. Author(s): V. Aoun, F. Varin, P. Hildgen, G. Leclair. VIEW ABSTRACT

360  Evaluation of a Novel Anti-inflammatory Estradiol-Loaded Omega-3-Fatty Acid Oil Containing Nanoemulsion Formulation for the Treatment of Atherosclerosis. Presenter: Dipti Deshpande, Northeastern University, U.S.A.. Author(s): D. Deshpande, K. Sankhe, M. Amiji. VIEW ABSTRACT

361  Evaluation of a novel targeting ligand to prepare mitochondriotropic liposomes with reduced cytotoxicity. Presenter: Parul Benien, Massachusetts College of Pharmacy & Health Sciences, U.S.A.. Author(s): P. Benien, E. M. Sheehan, M. A. Wagle, G. D'Souza. VIEW ABSTRACT

362  Evaluation of Micelles and Liposomes in an In-Vitro Articular Cartilage Explant Model. Presenter: Lisa Ferreira, Massachusetts College of Pharmacy and Health Sciences, U.S.A.. Author(s): L. V. Ferreira, A. Liang, K. Elsaid, G. D'Souza. VIEW ABSTRACT

363  Formation of Cationic Non PhospholipidLiposomes with Monoalkylated Primary Amine and Cholesterol. Presenter: Zhong-Kai Cui, Université de Montréal, CANADA. Author(s): Z. Cui, M. Lafleur. VIEW ABSTRACT

364  Formulation and Optimization of Chitosan Nanoparticles of BCS Class-III Drug Using Box-Behnken Design. Presenter: Ravi Patel, Department of Pharmaceutics & Pharmaceutical Technology, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa-388 421, Anand, Gujarat, INDIA. Author(s): R. R. Patel, B. Gajra, C. A. Dalwadi. VIEW ABSTRACT

365  Formulation and Optimization of the Itraconazole Lipid Polymeric Hybrid Nanoparticle by the Box-Behnken Design.. Presenter: Chintan Dalwadi, Department of Pharmaceutics and Pharmaceutical Technology, INDIA. Author(s): C. A. Dalwadi, R. R. Patel. VIEW ABSTRACT

366  Formulation of Docetaxel using Prodrugs for Intravenous Delivery. Presenter: Jin-Ki Kim, Hanyang University, KOREA. Author(s): Y. Na, C. Hwang, J. Baek, J. Park, J. Kim, C. Cho. VIEW ABSTRACT

367  HERBAL NANOFLAX: A New Paradigm for Epidermal Targeting and Alternative Treatment of Psoriasis. Presenter: Medha Patel, C.U.Shah College of Pharmacy, INDIA. Author(s): M. C. Patel, K. K. Singh. VIEW ABSTRACT

368  Hyaluronic acid-based nanoparticles for atherosclerosis imaging. Presenter: Jong-Ho Kim, Kyungpook National University, SOUTH KOREA. Author(s): J. Kim, G. Lee, J. Park, B. Lee, I. Kim. VIEW ABSTRACT

369  Influence if Solvent, Stabilizer, and Stabilizer's Concentration on the Physical Properties of PLGA Nanoparticles. Presenter: Aws Alshamsan, Assistant Professor, SAUDI ARABIA. Author(s): R. Alzahrani, A. Alshamsan. VIEW ABSTRACT

370  Investigation of Phase Behavior and Rheological Properties of PPG-5-CETETH-20 and Tetronics Surfactants Based Systems for Tetracycline Periodontal Formulations. Presenter: Flavia Carvalho, Faculdade de Ciências Farmacêuticas UNESP, BRAZIL. Author(s): F. C. Carvalho, T. Yu, M. D. Gremião, D. S. Jones. VIEW ABSTRACT

371  Investigation of Sirolimus liposomes using DSC and AFM. Presenter: Dennis Douroumis, University of Greenwich, School of Science, UNITED KINGDOM. Author(s): D. Douroumis, I. Onyesom, D. Lamprou, A. Urquhart. VIEW ABSTRACT

372  Liposomal Form of Prostaglandin E2 for Inhalation Treatment of Pulmonary Fibrosis. Presenter: Vera Ivanova, Rutgers, The State University of New Jersey, U.S.A.. Author(s): V. Ivanova, O. B. Garbuzenko, K. R. Reuhl, T. Minko. VIEW ABSTRACT

375  Micro-fluidic Structures for Zero-order and Sequential Drug Delivery. Presenter: Dasom Yang, Yonsei University, KOREA. Author(s): D. Yang, W. Ryu. VIEW ABSTRACT

376  Mixed Copolymer Nanoparticles for the Treatment of Drug Resistant Tumors: Formulation Development, Cytotoxicity and Pharmacokinetics. Presenter: Kevin Letchford, The University of British Columbia, CANADA. Author(s): K. Letchford, C. Wan, H. M. Burt. VIEW ABSTRACT

377  Mixed micelles with enhanced stability prepared from graft and diblock copolymers for doxorubicin delivery. Presenter: Yi Chun Chen, National Tsing Hua University, TAIWAN. Author(s): Y. Chen, G. Hsiue. VIEW ABSTRACT

378  Modified Gemcitabine-loaded lipid nanocapsules: when a drug participates to the structure of a nanomedicine. Presenter: Guillaume Bastiat, MINT, UMR_S 1066, FRANCE. Author(s): E. Moysan, G. Bastiat, A. Cieslak, N. Lautram, J. Béjaud, J. Benoit. VIEW ABSTRACT

379  Molecular dynamics simulation of PEGylated bilayers as model for the drug delivery liposome surface: interaction with salt ions and effect of formulation. Presenter: Alex Bunker, University of Helsinki, FINLAND. Author(s): A. Bunker, A. Magarkar, E. karakas, M. Stepniewski, T. Róg. VIEW ABSTRACT

380  Mucoadhesive Nanoparticles as Carrier Systems for Sublingual delivery of Glutathione. Presenter: Jingyuan Wen, School of Pharmacy, Faculty of Medical and Health Science, The University of Auckland, NEW ZEALAND. Author(s): G. Chen, J. Wen, C. Bunt. VIEW ABSTRACT

381  Multifunctional PEGylated 2C5-Immunoliposomes Containing pH-sensitive Bonds and TAT Peptide, in vitro and in vivo Activity. Presenter: Vladimir Torchilin, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, U.S.A.. Author(s): A. Apte, E. Koren, V. P. Torchilin. VIEW ABSTRACT

382  Multimeric Fullerenes for Rheumatoid Arthritis Therapy. Presenter: Dong Jin Lee, The Catholic University of Korea, SOUTH KOREA. Author(s): D. Lee. VIEW ABSTRACT

384  Nanoencapsulation of Tea Polyphenol into Biopolymeric Complex Coacervation Core Micelles. Presenter: Juan Li, College of Chemistry and Chemical Engineering, Central South University, PRC PEOPLES REP OF CHINA. Author(s): J. Li, H. Zhou, Y. Liu. VIEW ABSTRACT

385  Nanoparticle-assisted Boron Neutron Capture Therapy. Presenter: Yukio Nagasaki, Department of Materials Science, Graduate School of Pure and Applied Sciences, University of Tsukuba, JAPAN. Author(s): Y. Nagasaki, S. Sumitani, M. Oishi, T. Yaguchi, H. Murotani, Y. Horiguchi, M. Suzuki, K. Ono. VIEW ABSTRACT

386  Nanosizing of Nystatin for an Improved Antifungal Efficacy. Presenter: Alexandre Melkoumov, Université de Montréal, CANADA. Author(s): A. Melkoumov, G. Leclair, F. Louhichi, M. Raymond. VIEW ABSTRACT

387  New protocol to evaluate release in lipophilic medium: story of misinterpretation related to the use of fluorescent dyes. Presenter: Guillaume Bastiat, MINT, UMR_S 1066, FRANCE. Author(s): G. Bastiat, C. O. Pritz, F. Fouchet, E. Lignières, A. Schrott-Fischer, P. Saulnier, J. Benoit. VIEW ABSTRACT

388  Non-invasive in-vivo-monitoring of sustained nanosuspension release after s.c. application. Presenter: Alexandra Hill, Merck KGaA/Martin-Luther-University Halle (Saale), GERMANY. Author(s): A. Hill, S. Breyer, S. Geissler, W. Mier, M. Weigandt, K. Mäder. VIEW ABSTRACT

389  Oligonucleotide@Doxorubicin Nanoaggregates with Multiple Responsiveness toward Intracellular Release. Presenter: Sujin Yoon, Kangwon National University, KOREA. Author(s): S. Yoon, J. Choi, H. Kim, Y. Son, E. Jo, Y. Kim, J. Kang, H. Yoo. VIEW ABSTRACT

390  Optimization of a Novel Nanostructured Lipid Carriers for Ocular Herpes Simplex Keratitis. Presenter: Ali Seyfoddin, School of Pharmacy, The University of Auckland , Auckland, New Zealand, NEW ZEALAND. Author(s): A. Seyfoddin, J. A. Taylor, R. Al-Kassas. VIEW ABSTRACT

391  Optimization of Nanoparticle Fabrication Using D-Optimal Statistical Mixture Experimental Design. Presenter: Emmanuel Akala, Howard University, U.S.A.. Author(s): E. O. Akala, S. K. Adesina. VIEW ABSTRACT

392  Optimization of ophthalmic cyclosporine A nanoemulsion using in situ hydrogel system. Presenter: Seung-Yeob Kang, SKKU university, KOREA. Author(s): S. Kang, T. Oh, J. Seo, J. Han, C. Park, Y. Rhee, S. Chi, E. Park. VIEW ABSTRACT

393  Oral Absorption of PAMAM-SN38 Conjugate in Mice. Presenter: Shraddha Sadekar, Pharmaceutics and Pharmaceutical Chemistry, Center for Nanomedicine, Nano Institute of Utah, University of Utah, U.S.A.. Author(s): S. Sadekar, A. Ray, G. Thiagarajan, D. Hubbard, H. Ghandehari. VIEW ABSTRACT

394  Organic Nanotubes: Potential Nanocarriers for Doxorubicin. Presenter: Wuxiao Ding, National Institute of Advanced Industrial Science and Technology (AIST), JAPAN. Author(s): W. Ding, M. Masuda, T. Shimizu. VIEW ABSTRACT

395  Pancreatic Polypeptide in Phospholipid Micelles Exhibits Enhanced Stability Against Proteolytic Degradation and Retains its Bioactivity In Vitro. Presenter: Hayat Onyuksel, University of Illinois at Chicago, U.S.A.. Author(s): A. Banerjee, H. Onyuksel. VIEW ABSTRACT

397  PEGylation ofoxidized single-walled nanotubesfor sustained and pH-sensitive delivery ofdoxorubicin. Presenter: Samira Abolmaali, Department of Pharmaceutics, Shiraz Faculty of Pharmacy, IRAN. Author(s): A. M. Tamaddon, F. Farvadi, S. S. Abolmaali, Z. Sobhani. VIEW ABSTRACT

398  Peroral Delivery of 10-Hydroxycamptothecin-loaded polymeric nanomicelles. Presenter: Shirui Mao, Shenyang Pharmaceutical University, PRC PEOPLES REP OF CHINA. Author(s): S. Mao. VIEW ABSTRACT

399  pH/Thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-propylacrylic acid) copolymers for focused ultrasound-triggered release of doxorubicin. Presenter: Terence Ta, Boston University, U.S.A.. Author(s): T. Ta, A. J. Convertine, E. Park, C. R. Reyes, N. McDannold, P. S. Stayton, T. M. Porter. VIEW ABSTRACT

400  pH-Responsive Nanogel-Caged Lipid-Containing Polymeric Vesicles for Effective Intracellular Drug Delivery. Presenter: Hsin-Cheng Chiu, Department of Biomedical Engineering and Environmental Sciences, National Tsing Hua University, TAIWAN. Author(s): H. Chiu, W. Chiang, C. Wang. VIEW ABSTRACT

401  PLGA Nanoparticles Meet the Bronchial Airways: How Surface Properties Affect Their Interaction with Mucus and Epithelial Cells. Presenter: Herve Hillaireau, UMR CNRS, FRANCE. Author(s): H. Hillaireau, S. Mura, S. Kerdine-Romer, B. Le. Droumaguet, C. Delomenie, V. Nicolas, M. Pallardy, N. Tsapis, E. Fattal. VIEW ABSTRACT

402  Poloxamer 407/TPGS mixed micelles for delivery of gambogic acid to resistant cancer. Presenter: Muhammad Hussain, Texas A&M Health Science Center, U.S.A.. Author(s): M. D. Hussain, V. Saxena. VIEW ABSTRACT

403  Poly(amino oxalate) particles: A new drug carrier for the treatment of acute liver failure. Presenter: Dongwon Lee, Chonbuk National University, KOREA. Author(s): D. Lee, H. Kim, Y. Kim, G. Khang. VIEW ABSTRACT

404  Polymeric Chitosan-based Vesiclesas pH-responsive Drug Delivery System. Presenter: Ming-Cheng Wei, Industrial Technology Research Institute, TAIWAN. Author(s): M. Wei, Y. Ko, H. Liang, M. Lu. VIEW ABSTRACT

405  Polymeric Nanoparticles of Lopinavir to Improve its Oral Bioavailability. Presenter: Rahul Vats, BITS-Pilani,Hyderabad Campus, INDIA. Author(s): R. Vats, P. R. Ravi, A. N. Murthy. VIEW ABSTRACT

406  Polysaccharide Nanohydrogels as Drug Carriers. Presenter: Pietro Matricardi, 'Sapienza' University of Rome, Department of Drug Chemistry and Technologies, ITALY. Author(s): G. D'Arrigo, C. Di Meo, S. Chichiarelli, E. Gaucci, T. Coviello, F. Alhaique, P. Matricardi. VIEW ABSTRACT

407  Preparation and Characterisation of pH-responsive Polymeric Micelles Incorporating the Proteasome Inhibitor MG132 for Efficient Cancer Therapy.. Presenter: Sabina Quader, Department of Materials Engineering, Graduate School of Engineering, University of Tokyo, JAPAN. Author(s): S. Quader. VIEW ABSTRACT

409  Preparation, pharmacokinetics and tissue distribution of Lyophilized stealth Solid Lipid Nanoparticles Loaded Icariin. Presenter: Yang Wang, Tianjin University of Traditional Chinese Medicine, PRC PEOPLES REP OF CHINA. Author(s): Y. Wang. VIEW ABSTRACT

410  Reductive-sensitive tioguanine prodrug micelles. Presenter: André van der Vlies, Department of Applied Chemistry, Graduate School of Engineering, Osaka University , JAPAN. Author(s): A. J. van der Vlies, U. Hasegawa, J. A. Hubbell. VIEW ABSTRACT

411  Self-assembled Lipid Nanocapsules for Co-delivery of Paclitaxel and Bcl-2-targeted siRNA. Presenter: Mi Hwa Oh, Korea Advanced Institute of Science and Technology, SOUTH KOREA. Author(s): M. Oh, Y. Nam, J. Kim, J. Lee. VIEW ABSTRACT

412  Self-assembled nanoparticles from acetylated anionic polysaccharide as chemotherapeutic drug carrier. Presenter: Sin-jung Park, The Catholic University of Korea, SOUTH KOREA. Author(s): S. Park, K. Na. VIEW ABSTRACT

413  Simple and Effective Targeting for Programmed Erythrocyte Death by Using Cationic Liposomes. Presenter: Tatsuaki Tagami, Nagoya City University, JAPAN. Author(s): T. Tagami, R. Ito, H. Yanai, T. Ozeki. VIEW ABSTRACT

415  Study of structural organization of cationic emulsion/oligonucleotide complexes by energy dispersive X-ray diffraction. Presenter: Helder Teixeira, UFRGS, BRAZIL. Author(s): F. Bruxel, A. Malachias, R. Paniago, C. Perez, M. Oliveira, H. Teixeira. VIEW ABSTRACT

416  Surface Modification of Gelatin Nanoparticles with Polyethylenimine as Drug/Gene Vectors. Presenter: Min-Ju Chou, National Taiwan University, TAIWAN. Author(s): M. Chou, Y. Huang. VIEW ABSTRACT

417  Synthesis and characterization of a nanoglobular dendrimer 5-aminosalicylic acid conjugate with a Schiff base spacer for treating retinal diseases. Presenter: Zheng-Rong Lu, Case Western Reserve University, U.S.A.. Author(s): Z. Lu. VIEW ABSTRACT

418  Targeted Chemotherapy Using Electrostatic Charge Conversion of Tumor-identifying Polypeptides. Presenter: Nam Muk Oh, The Catholic University of Korea, SOUTH KOREA. Author(s): N. Oh. VIEW ABSTRACT

419  The control of T cell mediated immunity by anchorage effect using multi-segmented nanorod. Presenter: Sujin Yoon, Kangwon National University, KOREA. Author(s): S. Yoon, Y. Son, J. Choi, H. Kim, E. Jo, Y. Kim, J. Kang, H. Yoo. VIEW ABSTRACT

420  The cytotoxicity of paclitaxel loaded diblock copolymer nanoparticles in multidrug resistant cells is enhanced by low molecular weight methoxy poly(ethylene glycol)-block-poly(ε-caprolactone). Presenter: Chung Ping Leon Wan, University of British Columbia, CANADA. Author(s): C. Wan, K. Letchford, J. Jackson, H. M. Burt. VIEW ABSTRACT

421  The Effect of PEG-grafted-PLA Nanoparticles Loaded with Famotidine on Apical Efflux Using CaCo-2 Cell Monolayer.. Presenter: Mohamed Mokhtar, Universite de Montreal, CorealisPharma Inc, CANADA. Author(s): M. E. Mokhtar, P. Gosselin, P. Hildgen. VIEW ABSTRACT

423  Trimethyl Chitosan coated Propyl Starch Nanoparticles for Gene Silencing. Presenter: Ratnesh Jain, Nanomedicine Lab, Department of Pharmaceutical Sciences and Technology, INDIA. Author(s): R. Jain, P. Dandekar-Jain, B. Loretz, G. Wenz, C. Lehr. VIEW ABSTRACT

424  Tumor selective targeting and light induced cytotoxicity of Zn-protoporphyrin conjugated hydroxypropylmethacrylamide polymer (HPMA-ZnPP) micelle.. Presenter: Hideaki Nakamura, Institute for Drug Delivery System, Sojo University, JAPAN. Author(s): H. Nakamura, Q. Haibo, L. Long, V. Subr, Y. Hitaka, F. Jun, K. Ulbrich, H. Maeda. VIEW ABSTRACT

425  Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment. Presenter: Roy van der Meel, Dept. of Pharmaceutics, Utrecht Institute for Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, NETHERLANDS. Author(s): R. van der Meel, S. Oliveira, I. Altintas, R. Haselberg, J. van der Veeken, R. C. Roovers, P. van Bergen en Henegouwen, G. Storm, W. E. Hennink, R. M. Schiffelers, R. J. Kok. VIEW ABSTRACT

426  Tumor-Targeting and Boron Neutron Capture Therapy by Using Biodegradable Polyamines Conjugated with Boron Cluster. Presenter: Takeshi Nagasaki, Osaka City University, JAPAN. Author(s): T. Nagasaki, Y. Zhu, H. Azuma, M. Kirihata, S. Masunaga, K. Ono. VIEW ABSTRACT

427  Ultrasound-responsive thrombus treatment with zinc-stabilized gelatin nano-complexes of tissue-type plasminogen activator. Presenter: Yoshiko Uesugi, Kyoto University, JAPAN. Author(s): Y. Uesugi, H. Kawata, Y. Saito, Y. Tabata. VIEW ABSTRACT

429  Water soluble polymeric xanthine oxidase inhibitor, PEG-AHPP micelles, as a novel therapeutic for ROS related inflammatory bowel diseases. Presenter: JUN FANG, Laboratory of Microbiology & Oncology, Faculty of Pharmaceutical Sciences, Sojo University, JAPAN. Author(s): J. FANG, G. Bharate, H. Qin, H. Nakamura, H. Maeda. VIEW ABSTRACT

430  Well-defined prodrug micelles for non-steroidal anti-inflammatory drug delivery. Presenter: Urara Hasegawa, Graduate School of Engineering, Osaka University, JAPAN. Author(s): U. Hasegawa, A. J. van der Vlies, C. Wandrey, J. A. Hubbell. VIEW ABSTRACT

Oncology and Tumor Targeting     [RETURN TO TOP]

431  3D Superhydrophobic Electrospun Materials for Prolonged Drug Delivery of SN-38 in Colorectal Cancer Treatment. Presenter: Stefan Yohe, Departments of Biomedical Engineering and Chemistry, Boston University, U.S.A.. Author(s): S. T. Yohe, Y. L. Colson, M. W. Grinstaff. VIEW ABSTRACT

432  A Biophysical Transport Model To Predict The Enhanced Permeability And Retention Effect For Liposome Accumulation In Solid Tumours. Presenter: Shawn Stapleton, Medical Biophysics, University of Toronto, CANADA. Author(s): S. Stapleton, M. Milosevic, C. Allen, D. Jaffray. VIEW ABSTRACT

433  A Novel High-Performance Thin-Layer Chromatography Method for the Quantitative Determination of Clofazimine. Presenter: Varun Kapoor, University Institute of Pharmaceutical Sciences, Panjab University, INDIA. Author(s): V. R. Kapoor, S. Goindi, N. Kumar. VIEW ABSTRACT

435  Accumulation and biodistribution of 'Stealth Liposomes' and plasmapheresis. Presenter: Romeo Ngoune, University Medical Center of Freiburg, GERMANY. Author(s): R. Ngoune, V. Maks, M. Meissner, D. von. Elverfeldt, K. Winkler, G. Pütz. VIEW ABSTRACT

436  Antiangiogenic Effect of Paclitaxel and Rapamycin Polymeric Micelles Individually and in Combination. Presenter: Adam Alani, Oregon State University, U.S.A.. Author(s): G. P. Mishra, A. G. Alani. VIEW ABSTRACT

437  Anti-tumour effect of Sirolimus stealth liposomes on human breast cancer cells (BT-474). Presenter: Dennis Douroumis, University of Greenwich, School of Science, UNITED KINGDOM. Author(s): D. Douroumis, I. Onyesom. VIEW ABSTRACT

438  Bladder Tumor-Targeted Delivery of a Pro-apoptotic Peptide. Presenter: Hyun Kyung Jung, Kyungpook National University (Knu), South Korea. Author(s): H. Jung, I. Kim, B. Lee. VIEW ABSTRACT

439  Cancer Cell Spheroids as a Model to Study Sequential Chemotherapy Protocols. Presenter: Federico Perche, Center for Pharmaceutical Biotechnology and Nanomedicine, U.S.A.. Author(s): F. Perche, V. P. Torchilin. VIEW ABSTRACT

441  Chemoresistance in Prostate Cancer Cells is Regulated by miRNAs and Hedgehog Pathway. Presenter: Saurabh Singh, University of Tennessee Health Science Center, U.S.A.. Author(s): S. Singh, D. Chitkara, S. W. Behrman, R. I. Mahato. VIEW ABSTRACT

442  Combination Anticancer Nanopreparations of Novel Proapoptotic Drugs and TRAIL Ligand. Presenter: Robert Riehle, Northeastern University, U.S.A.. Author(s): R. D. Riehle, S. Cornea, I. Skidan, A. Degterev, V. P. Torchilin. VIEW ABSTRACT

444  Controlled water steam injection: ex vivo optimization of parameters for the ablation of liver lesions. Presenter: Nathalie Stransky, University of Geneva, SWITZERLAND. Author(s): N. Stransky, S. Lugbull, S. Mouton, E. Hiltbrand, Y. Martin, S. Humbert, E. Allémann. VIEW ABSTRACT

446  Design and Development of Tumour-targeting Solid Lipid Nanoparticles for a Novel Inhibitor of Nedd8-Activating Enzyme. Presenter: Siddhesh Patil, Millennium Pharmaceuticals, Inc, U.S.A.. Author(s): S. D. Patil, J. Yang, T. Traore, S. Yazdi, A. Loxley, Q. McCubbin. VIEW ABSTRACT

447  Design of a Novel Peptide for HER2 Targeting Based on Pertuzumab-HER2 Complex. Presenter: Xiaoling Li, University of the Pacific, U.S.A.. Author(s): D. Su, B. Jasti, X. Li. VIEW ABSTRACT

449  Development of Functionalized Iron Oxide Nanoparticles for Cancer Detection. Presenter: Neelam Chavan, Postdoctoral fellow, U.S.A.. Author(s): N. Chavan, M. Bikram, J. Young, R. Drezek, J. Almaguer, C. Karmonik, A. Brazdeikis. VIEW ABSTRACT

450  Distribution and functional analysis of Eph receptor A10 as a novel drug target for breast cancer. Presenter: Yuka Maeda, National Institute of Biomedical Innovation, JAPAN. Author(s): Y. Maeda, K. Nagano, T. Yamashita, S. Kanasaki, T. Furuya, M. Inoue, H. Nabeshi, T. Yoshikawa, Y. Yoshioka, N. Itoh, Y. Abe, H. Kamada, Y. Tsutsumi, S. Tsunoda. VIEW ABSTRACT

451  Enhacement anticancer effect of Baicalein and Gemcitabine using multifunctional solid lipid nanoparticle on A549 cells line. Presenter: Ming-Jun Tsai, Department of Neurology, China Medical University Hospital, TAIWAN. Author(s): M. Tsai, T. Weng, M. Lin, C. Huang, Y. Tsai. VIEW ABSTRACT

452  Enhanced Anticancer Activity by Specific Target Effect using anti-HER2 antibody and LMPXPEG. Presenter: Mi-Kyeong Jang, Sunchon National University, KOREA. Author(s): M. Jang, J. Nah. VIEW ABSTRACT

453  Fatty Acid-Glycosylated RGD Amphiphiles for Targeted Delivery of Paclitaxel to TumorsOverexpressing α νβ3 Integrins:In Vitro Cellular Uptake and Cytotoxicity Studies. Presenter: Xiaoling Li, University of the Pacific, U.S.A.. Author(s): P. S. Saraf, N. Javali, X. Li, B. Jasti. VIEW ABSTRACT

454  In Situ Hydrogel for the Sustained Release of Anti-Cancer Drug. Presenter: Maggie Lu, ITRI, TAIWAN REP OF CHINA. Author(s): M. Lu, Y. Lo, M. Lin, C. Huang, T. Hu, S. Chou, C. Tu. VIEW ABSTRACT

455  In Vivo Stability of an Injectable Antibody Displaying System. Presenter: Yi Wen, Division of Pharmaceutical Science, Duquesne University, Pittsburgh, PA, U.S.A.. Author(s): Y. Wen, W. S. Meng, H. Kolonich, E. S. Gawalt, N. Giannokakis. VIEW ABSTRACT

456  Nanocomposite particles for treatment of lung carcinoma. Presenter: Keishiro Tomoda, Tokyo University of Science, JAPAN. Author(s): K. Tomoda, K. Hirota, T. Nakajima, H. Terada, K. Makino. VIEW ABSTRACT

457  Nanomaterials Targeting the Extracellular Matrix-Modifying Enzyme Lysyl Oxidase (LOX) that Inhibit Mammary Tumor Growth. Presenter: Mathumai Kanapathipillai, Postdoctoral Fellow, U.S.A.. Author(s): M. Kanapathipillai, A. Mammoto, T. Mammoto, J. Kang, E. Jiang, K. Ghosh, N. Korin, A. Gibbs, R. Mannix, D. Ingber. VIEW ABSTRACT

458  New self-assembling nanoparticles for bisphosphonate and nucleic acid delivery in cancer. Presenter: Giuseppe De Rosa, University Federico II of Naples, ITALY. Author(s): G. Salzano, M. Marra, S. Zappavigna, M. Caraglia, M. Porru, C. Leonetti, A. Abbruzzese, M. La Rotonda, G. De Rosa. VIEW ABSTRACT

459  Novel C16-ADA linked RGD micelles for targeted delivery of hydrophobic agents toα νβ3 integrin receptors. Presenter: Xiaoling Li, University of the Pacific, U.S.A.. Author(s): A. Raj, L. Wrischnik, M. Alhamadsheh, X. Li, B. Jasti. VIEW ABSTRACT

460  Novel pH Switchable Micelle/Polymerosome Vehicles For Controlled Release Of Anticancer Drugs. Presenter: Stefano Salmaso, Department of Pharmaceutical Sciences, University of Padua, ITALY. Author(s): F. Mastrotto, S. Salmaso, E. Ravazzolo, C. Alexander, G. Mantovani, P. Caliceti. VIEW ABSTRACT

461  Phosphatidylcholines in Anticancer Drug Delivery - mere innocent Bystanders? Presenter: Annette Peters, University Medical Center Freiburg, GERMANY. Author(s): A. Peters, K. Winkler, G. Puetz. VIEW ABSTRACT

462  pH-Sensitive PEGylated Liposomes For Tumour Cell Targeting. Presenter: Stefano Salmaso, Department of Pharmaceutical Sciences, University of Padua, ITALY. Author(s): E. Ravazzolo, F. Mastrotto, P. Caliceti, S. Salmaso. VIEW ABSTRACT

463  Polyethylene Glycol–Phosphatidylethanolamine(PEG–PE)/Vitamin E Based Micelles for the Co-Delivery of Paclitaxel and Curcumin to Overcome Multi-Drug Resistance in Cancer. Presenter: Abraham Abouzeid, Northeastern University , U.S.A.. Author(s): A. H. Abouzeid, V. P. Torchilin. VIEW ABSTRACT

464  Potential of Angiogenesis Target using Cationic polymer and RGD Peptide. Presenter: MiKyeong Jang, Sunchon National University, KOREA. Author(s): M. Jang, J. Nah. VIEW ABSTRACT

467  Sequential dose of l-OHP containing PEGylated liposome improve the intratumor delivery and efficacy of PEGylated liposomal anticancer agents.. Presenter: Hiroyuki Nakamura, Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences,The University of Tokushima, JAPAN. Author(s): H. Nakamura, Y. Doi, T. Ishida, H. Kiwada. VIEW ABSTRACT

471  Synthesis and Characterization of Active targeting Agent using Transferrin for Cancer Therapy. Presenter: Jae-Woon Nah, Sunchon National University, KOREA. Author(s): J. Nah, M. Jang. VIEW ABSTRACT

472  Systems Nanotechnology to Amplify Tumor Targeting. Presenter: Ji Ho Park, KAIST, KOREA. Author(s): J. Park, G. von Maltzahn, E. Ruoslahti, S. N. Bhatia, M. J. Sailor. VIEW ABSTRACT

474  Targeting Ligand-directed Micellar Nanocarriers for R547: Enhanced Binding and Increased Cytotoxicity to Cancer Cells. Presenter: Rupa Sawant, Northeastern University, U.S.A.. Author(s): R. Sawant, A. Jhaveri, F. Qureshi, V. Torchilin. VIEW ABSTRACT

476  Three Dimensional Spheroid Culture: Evaluation and Comparison of Cancer Cell Behavior. Presenter: Niravkumar Patel, Northeastern University, U.S.A.. Author(s): N. R. Patel, B. Aryasomayajula, D. Mongayt, V. P. Torchilin. VIEW ABSTRACT

478  Tumor Vasculature Targeted Size Controlled PEGylated Liposomal Delivery System To Treat Chemotherapy Resistant Renal Cell Carcinoma. Presenter: Golam Kibria, Hokkaido University, JAPAN. Author(s): G. Kibria, H. Hatakeyama, N. Ohga, K. Hida, H. Harashima. VIEW ABSTRACT

479  Use of macrophages as a tool for delivery of therapeutic and imaging contrast agents to tumors. Presenter: Jinhyang Choi, ASAN Medical Center, SOUTH KOREA. Author(s): J. Choi. VIEW ABSTRACT

706  Surface Charge Switchable Nanoparticles Based on Zwitterionic Polymer for Enhanced Drug Delivery to Tumor. Presenter: J. Wang, University of Science and Technology, PRC PEOPLES REP OF CHINA. Author(s): J. Wang, Y. Yuan, C. Mao, X. Du, J. Du, F. Wang. VIEW ABSTRACT

Oral Controlled Release     [RETURN TO TOP]

480  A Hydrophilic Matrix Generated by Direct Compression and Thermal Treatment: Application in Press-Coating. Presenter: Paolo Gatti, Aptalis Pharma S.r.l., ITALY. Author(s): G. Caviglioli, S. Baldassari, P. Cirrincione, E. Russo, B. Parodi, S. Cafaggi, P. Gatti. VIEW ABSTRACT

481  A New Hydrophilic Bioadhesive Matrix for Controlled Drug Release Generated in Direct Compression Tablets by Thermal Treatment: Mechanism Elucidation. Presenter: Sara Baldassari, University of Genova, ITALY. Author(s): G. Caviglioli, S. Baldassari, P. Cirrincione, E. Russo, B. Parodi, S. Cafaggi, M. Garavaglia, P. Gatti. VIEW ABSTRACT

483  A novel porous starch based self-assembled nano-delivery system improves the oralabsorption of insoluble probucol in rats. Presenter: Zhiwen Zhang, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, PRC PEOPLES REP OF CHINA. Author(s): Z. Zhang, Y. Li. VIEW ABSTRACT

484  A Novel Semi Empirical Approach For Extrusion Spheronization Based Formulations. Presenter: Abhijit Gokhale, Patheon Pharmaceutical Development Services, U.S.A.. Author(s): A. A. Gokhale, Y. Chachare, S. Sathigari, B. Stagner, R. Kasina, A. Qu. VIEW ABSTRACT

485  A Taste Masking Coating Using CelluloseDerivatives. Presenter: Sakae Obara, Shin-Etsu Chemical Co., Ltd., JAPAN. Author(s): M. Fukasawa, Y. Nishiyama, S. Obara. VIEW ABSTRACT

486  Barrier Membrane Coating of Hydrophilic Matrices of a Very Soluble Drug, Metoprolol Tartrate at High Dose: A Strategy to Eliminate the Initial Burst Release. Presenter: Ali Rajabi-Siahboomi, Colorcon Inc., U.S.A.. Author(s): R. Y. Mehta, S. Missaghi, T. P. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

487  Bioadhesion study of liquid crystalline systems on the tooth surface. Presenter: Giovana Calixto, State University of São Paulo, BRAZIL. Author(s): G. Calixto, M. Garcia, M. Chorilli. VIEW ABSTRACT

488  Bioavailability Enhancement of Itraconazole with Solid Solutions based on Polyethylene glycol-Polyvinyl Caprolactam- Polyvinyl Acetate Graft Copolymer. Presenter: Karl Kolter, R&D Pharma Ingredients, BASF SE, GERMANY. Author(s): F. Guth, M. Becker, R. Buesen, K. Kolter. VIEW ABSTRACT

489  Buccal delivery of insulin used a novel mucoadhesive polymer. Presenter: Elaheh Mortazavian, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical Sciences, IRAN. Author(s): E. Mortazavian, M. Amini, F. Abedin. Dorkoosh, M. Rafiee. Tehrani. VIEW ABSTRACT

491  Characterization of nanostructured lipid carries containing Praziquantel by DSC. Presenter: Fernanda dos Santos, Faculty of Pharmaceutical Sciences - UNESP, Araraquara, SP, Brazil, BRAZIL. Author(s): F. K. dos. Santos. VIEW ABSTRACT

492  Characterization of the Mechanical Properties of High Drug Loading Pellets for Compressed CR Tablets. Presenter: Xiaodi Guo, Prinston Pharmaceutical Inc, U.S.A.. Author(s): J. Li, S. Yang, H. Zhao, R. Luo, K. Lu, H. Chen, M. Wang, J. Du, X. Guo. VIEW ABSTRACT

493  Chrono – Delivery of Hydrocortisone Tablets Processed by Hot-Melt Extrusion (HME). Presenter: Dennis Douroumis, University of Greenwich, School of Science, UNITED KINGDOM. Author(s): D. Douroumis, M. Maniruzzaman, A. Hossain, J. C. Mitchell. VIEW ABSTRACT

495  Coated pellets containing chitosan for colon targeting. Presenter: Priscileila Ferrari, Departamento de Física e Biofísica, IBB, UNESP, BRAZIL. Author(s): P. C. Ferrari, F. M. Souza, L. Giorgetti, G. F. Oliveira, H. G. Ferraz, R. C. Evangelista. VIEW ABSTRACT

496  Comparative Evaluation of Tablet Properties prepared by new Super Fine Powder, Special Low Viscosity Grade of Hydroxypropyl Cellulose (HPC-SSL-SFP). Presenter: Kenji Sugisawa, Nippon Soda Co., Ltd., JAPAN. Author(s): K. Sugisawa. VIEW ABSTRACT

497  Comparative Study of High Viscosity Grade of Hydroxypropyl Cellulose (HPC-H) for Hydrophilic Matrix, Sustained Release Formulation. Presenter: Kenji Sugisawa, Nippon Soda Co., Ltd., JAPAN. Author(s): K. Sugisawa. VIEW ABSTRACT

498  Compatibility studies with tablet excipients in solid state using Raman spectroscopy, X-ray and Scanning electron microscopy. Presenter: Manuel Vueba, Unidade de I&D 'Química Física Molecular', Faculdade de Ciencias e Tecnologia da Universidade de Coimbra, 3004-535 Coimbra, Portugal, PORTUGAL. Author(s): M. L. Vueba, M. E. Pina, L. B. De Carvalho. VIEW ABSTRACT

499  Design of Acyclovir Loaded Nanoparticles for Controlled Delivery System. Presenter: Shadab Shahsavari, Chemical Engineering Department, IAU, Scince and Reasearch Campus, IRAN. Author(s): F. Abedin. Dorkoosh, S. Shahsavari, E. Vasheghani. Farahani, M. Ardjmand. VIEW ABSTRACT

500  Design of granules based on Casearia sylvestris to treatment of gastric diseases: preliminary issues.. Presenter: Alexandre Crispim, Faculdade de Ciencias Farmaceuticas de Araraquara - UNESP, BRAZIL. Author(s): A. Crispim, P. Ferrari, A. dos Santos, A. de Castro. VIEW ABSTRACT

501  Design of Maillard Conjugates-Stabilized Chitosan Nanoparticles for Colon-specific Oral Delivery System. Presenter: Juan Li, Université Laval, CANADA. Author(s): J. Li, M. Subirade. VIEW ABSTRACT

502  Determining the microstructure of oral microemulsions containing Brij and Capmul.. Presenter: Adwoa Nornoo, Palm Beach Atlantic University, U.S.A.. Author(s): P. Nguebo, L. Calvo, H. Yoon, A. Nornoo. VIEW ABSTRACT

503  Development and validation of an isocratic RP-HPLC method for determination of bovine lactoferrin and its proteolytic degradation in simulated gastrointestinal fluids. Presenter: Jingyuan Wen, Univerisity of Auckland, NEW ZEALAND. Author(s): J. Wen, X. Yao, S. Quek, J. Cornish, C. Bunt. VIEW ABSTRACT

504  Development of a Pulsatile Release Multiparticulate System for Delivery of Ondansetron. Presenter: Sanjay Konagurthu, Bend Research Inc., U.S.A.. Author(s): S. Konagurthu. VIEW ABSTRACT

505  Development of Alternative Formulations of a Poorly Water-Soluble Drug, MK-0364, Using a Solid Dispersion Approach, Part I: Initial Screening Using a Solvent Casting Method. Presenter: Sutthilug Sotthivirat, Merck & Co., Inc., U.S.A.. Author(s): S. Sotthivirat, C. McKelvey, J. Moser, B. Rege, W. Xu, D. Zhang. VIEW ABSTRACT

506  Development Of An Expert System For The Prediction Of Controlled Release Formulations. Presenter: Yuda Zong, Ashalnd Specialty Ingredients, U.S.A.. Author(s): Y. Zong, T. Durig, D. Tewari, Z. Lian. VIEW ABSTRACT

507  Development of Injection-Molded Swellable/Erodible Capsules for Oral Pulsatile Release. Presenter: Giulia Loreti, Dipartimento di Scienze Farmaceutiche, Universit degli Studi di Milano, ITALY. Author(s): L. Zema, G. Loreti, E. Macchi, M. Cerea, A. Foppoli, A. Gazzaniga. VIEW ABSTRACT

508  Development of Modified Release Formulations of Gabapentin for Relief of Symptoms accompanying the Female Menopause. Presenter: Mark Powell, Quay Pharmaceuticals, UNITED KINGDOM. Author(s): M. Powell, M. Frodsham, B. Sanghera, J. Collett. VIEW ABSTRACT

509  Development of mucoadhesive liquid crystalline systems for buccal drug delivery using tea tree oil with oil phase. Presenter: Marlus Chorilli, UNESP, BRAZIL. Author(s): M. Chorilli. VIEW ABSTRACT

512  Direct in situ determination of structural aspects of rapid solvent-mediated polymorphic transitions during dissolution using synchrotron XRD. Presenter: Ben Boyd, Monash Institute of Pharmaceutical Sciences, AUSTRALIA. Author(s): B. J. Boyd, J. Botker, J. Rantanen, T. Rades, A. Hawley. VIEW ABSTRACT

514  Dissolution Enhancement of Poorly Water-Soluble APIs Prepared by Hot-Melt Extrusion (HME) using Hydrophilic Polymers. Presenter: Dennis Douroumis, University of Greenwich, School of Science, UNITED KINGDOM. Author(s): D. Douroumis, M. Maniruzzaman, M. M. Rana, J. S. Boateng. VIEW ABSTRACT

515  Dissolution experiments at varying pH in presence of lipid layer to mimic absorption and using polymers to prevent drug precipitation. Presenter: Jon Mole, Sirius Analytical Inc., U.S.A.. Author(s): J. J. Mole, K. J. Box, J. Comer, R. Taylor. VIEW ABSTRACT

516  Dissolution of Ranolazine ER tablets under standard and biorelevant mechanical stress conditions. Presenter: Grzegorz Garbacz, University of Greifswald / Physiolution GmbH, GERMANY. Author(s): G. Garbacz, M. Pötzsch, J. Maazgalski, W. Weitschies. VIEW ABSTRACT

517  Efavirenz –Polymer Hot Melt Extrusion Systems For Dissolution Enhancement: Physico-Mechanical Characerization And Drug Release Studies. Presenter: Sateesh Kumar Sathigari, Patheon Pharmaceuticals, U.S.A.. Author(s): S. Sathigari, J. Ramapuram, D. L. Parsons. VIEW ABSTRACT

518  Effect of polymer properties on drug dissolution from solid dispersions : Solubility parameters and surface tention. Presenter: Fumie Tanno, Shin-Etsu Chemical Co., Ltd., JAPAN. Author(s): F. K. Tanno. VIEW ABSTRACT

520  Effect of Granulation Processing Parameters on Performance of Push-Pull Osmotic Pump Tablets of a Practically Water Insoluble Model Drug. Presenter: Ali Rajabi-Siahboomi, Colorcon, U.S.A.. Author(s): P. Patel, S. Missaghi, T. P. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

521  Effect of Solution and Polymer Properties on Spray Dried Powder Properties. Presenter: Mohammed Rahman, Ashland Specialty Ingredients, U.S.A.. Author(s): M. Rahman, J. D. Lester, S. Ozkan, V. Bi, T. Durig. VIEW ABSTRACT

522  Encapsulation Prevents Chemical Incompatibility in Combination Therapy. Presenter: Daniel Bar-Shalom, University of Copenhagen, DENMARK. Author(s): D. Bar-Shalom, A. Hounsgaard, K. Naelapää. VIEW ABSTRACT

523  Evaluating an alternative to fluid bed technology for drug layering and for applying functional coats onto pellets. Presenter: Thorsten Cech, BASF SE, Application Lab Pharma Ingredients & Services Europe, GERMANY. Author(s): L. Baginski, F. Bang, T. Cech, F. Cembali, C. Funaro, G. Mondelli. VIEW ABSTRACT

524  Evaluating various hydrophilic plasticisers regarding their effect on the characteristics of a gastric resistant coat based on methacrylic ethyl acrylate copolymer. Presenter: Thorsten Cech, BASF SE, Application Lab Pharma Ingredients & Services Europe, GERMANY. Author(s): T. Agnese, T. Cech, T. Rillmann. VIEW ABSTRACT

525  Evaluating various insoluble components regarding their effect on the processability and charac-teristics of a gastric resistant coat based on methacrylic ethyl acrylate copolymer. Presenter: Thorsten Cech, BASF SE, Application Lab Pharma Ingredients & Services Europe, GERMANY. Author(s): T. Agnese, T. Cech, F. Wildschek. VIEW ABSTRACT

526  Evaluation of dissolution and permeation by verted gut sac technique of solid dispersion zidovudine. Presenter: Fabíola Prezotti, Faculdade de Ciencias Farmaceuticas – University Estadual Paulista – UNESP, BRAZIL. Author(s): L. N. Pedreiro, F. G. Prezotti, B. S. Ferreira. Cury, M. D. Gremião. VIEW ABSTRACT

528  Extended release acetaminophen- psyllium husk matrix tablet and the effect of additives on the drug release rate kinetics and mechanism. Presenter: Nagin Patel, Long island university, U.S.A.. Author(s): N. K. Patel. VIEW ABSTRACT

529  Extended Release Oral Formulation for the Treatment of Hypothyroidism. Presenter: Mark Powell, Quay Pharmaceuticals, UNITED KINGDOM. Author(s): M. Powell, J. Farrar, A. Nagle, M. Frodsham, J. Collett, H. Huatan, R. Ross. VIEW ABSTRACT

530  Formulation and Process Deviation Analysis for Scale Up of Extended-Release Drug Products of Abbreviated New Drug Applications by Quality Risk Management Principles (ICH Q9). Presenter: Yanning Lin, Food and Drug Administration, U.S.A.. Author(s): Y. Lin, U. V. Venkataram, G. J. Smith. VIEW ABSTRACT

533  Hot-Melt Microsphere Fabrication for Controlled Release of Orally Delivered Small Molecules. Presenter: David Dumbauld, Orbis Biosciences, U.S.A.. Author(s): M. Singh, D. W. Dumbauld, C. Berkland. VIEW ABSTRACT

534  Improved oral bioavailability of risedronate by DA-1, as a novel absorption enhancer. Presenter: Jeong-Soo Kim, Research Center of Dong-A Pharm., SOUTH KOREA. Author(s): J. Kim, D. Ryu, W. Ku, S. Jang, M. Son. VIEW ABSTRACT

535  Improving drug safety: Compritol® 888 ATO matrix tablets deliver consistent sustained drug release in hydro-alcoholic media and when broken.. Presenter: Delphine Marchaud, Gattefossé, FRANCE. Author(s): D. Marchaud, Y. Cuppok, E. Dauphin-Chanard, K. Arcuri, J. Girard, C. Miolane. VIEW ABSTRACT

536  In vitro evaluation of floating ability and drug release of tablets containing magnetic marker. Presenter: Priscileila Ferrari, Departamento de Física e Biofísica, IBB, UNESP, BRAZIL. Author(s): P. C. Ferrari, R. C. Evangelista, J. A. Miranda. VIEW ABSTRACT

537  In vivo and in vitro evaluations of lipid matrix nanoparticles containing fenofibrate. Presenter: Huiling Mu, University of Copenhagen, DENMARK. Author(s): H. Mu. VIEW ABSTRACT

538  Incorporating Polymers into Softgel Capsule Fills for Extended Release. Presenter: Yunhua Hu, Banner Pharmacaps, U.S.A.. Author(s): Y. Hu, Q. Fang, M. Hariharan, A. Fatmi. VIEW ABSTRACT

539  Influence of b-Cyclodextrin Side Chain Substitutions on the Complexation Efficiency of Two Model BCS Class II Compounds. Presenter: Carmen Popescu, Roquette America Inc., U.S.A.. Author(s): C. Popescu, C. J. Wiley, L. Zhou, P. Lefevre, L. Felton. VIEW ABSTRACT

540  Influence of solvents on the characteristics and drug release of microparticles prepared using electrospraying. Presenter: Adam Bohr, University College London, DENMARK. Author(s): A. Bohr, F. Wan, J. Kristensen, M. Edirisinghe, M. Yang. VIEW ABSTRACT

541  In-situ solubility measurements of ionizable drugs and precipitation behaviour in the presence and absence of Plasdone polymer crystallisation inhibitors. Presenter: Jon Mole, Sirius Analytical Inc., U.S.A.. Author(s): J. Mole, K. J. Box, J. Comer, R. Taylor, V. Bi. VIEW ABSTRACT

543  Investigation effect of sodium Meta bisulphite and various filler types on release stability of diltiazem hydrochloride containing Poly ethylene oxides. Presenter: Saeed Shojaee, University Of Kent, UNITED KINGDOM. Author(s): S. Shojaee, A. Nokhodchi, I. Cumming. VIEW ABSTRACT

544  Investigation of barrier film changes during dissolution testing to rationalize controlled release pellet formulations. Presenter: Michael Pollitt, MSD, Hoddesdon, UNITED KINGDOM. Author(s): M. J. Pollitt, G. B. Hatton, C. Seiler. VIEW ABSTRACT

545  Investigation of Cellulose Acetate Polymer Viscosity and Coating Solution Concentration on Performance of Push-Pull Osmotic Pump (PPOP) Tablets. Presenter: Hua Deng, Colorcon, U.S.A.. Author(s): L. Martin, H. Deng, S. Missaghi, T. Farrell, A. Rajabi-Siahboomi. VIEW ABSTRACT

546  InVitro Release Behavior of Insulin in the IPN Hydrogel as Oral Drug Delivery. Presenter: Athir Haddad, University of Basrah, IRAQ. Author(s): A. M. Haddad, D. S. Ali, A. A. Aladdai. VIEW ABSTRACT

547  IPEC-Americas New Excipient Safety Evaluation Procedure. Presenter: David Schoneker, Colorcon, U.S.A.. Author(s): C. DeMerlis, D. Schoneker. VIEW ABSTRACT

548  Manufacturing and Process Controls of Controlled Release Dosage Forms-- Investigation of Post-approval Changes Required During the Product Life Cycle. Presenter: Shrikant Pagay, FDA/CDER, YEMEN. Author(s): S. Pagay, A. Yu, M. Sloan, T. Wang. VIEW ABSTRACT

549  MESALAMINE – Novel Delayed Delivery System. Presenter: Mihaela Friciu, Université du Québec Montréal, CANADA. Author(s): M. M. Friciu, T. Le, P. Ispas. Szabo, M. Arella, M. A. Mateescu. VIEW ABSTRACT

550  Modification, modeling and characterization of an interpolyelectrolyte complex as a hydrogel for gastroretention. Presenter: Ndidi Ngwuluka, University of the Witwatersrand, REP OF SOUTH AFRICA. Author(s): N. C. Ngwuluka, V. Pillay, Y. E. Choonara, L. C. du Toit, P. Kumar, T. Snyman. VIEW ABSTRACT

552  Monitoring Drug Release from Self-emulsifying Drug Delivery Systems Real TIme during In Vitro Formulation Digestion: A Modeling Approach. Presenter: Rebecca Carrier, Associate Professor, U.S.A.. Author(s): F. Buyukozturk, D. E. Budil, R. L. Carrier. VIEW ABSTRACT

553  Mucoadhesive and swelling properties of free films of high amylose-pectin mixtures modified by cross-linking or retrogradation. Presenter: Fabíola Prezotti, Faculdade de Ciencias Farmaceuticas – University Estadual Paulista – UNESP, BRAZIL. Author(s): F. G. Prezotti, A. B. Meneguin, B. S. Ferreira. Cury, R. C. Evangelista. VIEW ABSTRACT

554  Multiple-Unit Swellable/Erodible Delivery System for Oral Pulsatile Release: Preliminary Stability and In Vivo Evaluation. Presenter: Giulia Loreti, Dipartimento di Scienze Farmaceutiche, Universit degli Studi di Milano, ITALY. Author(s): M. D. Del. Curto, A. Maroni, L. Palugan, G. Loreti, A. Melocchi, A. Gazzaniga. VIEW ABSTRACT

555  Oral Delivery of Multiple Drugs from a Multi-Reservoir Bioadhesive Microdevice. Presenter: Hariharasudhan Chirra D, University of California at San Francisco, U.S.A.. Author(s): H. Chirra. D, T. A. Desai. VIEW ABSTRACT

556  Oral Disintegration Tablet for Carbamazepine Solid Dispersion. Presenter: Yidan Lan, BASF, U.S.A.. Author(s): Y. Lan, N. Langley. VIEW ABSTRACT

558  Orally Bioactive Mucoadhesive Intestinal Calcitonin Delivery Systems. Presenter: Vivek Gupta, University of California Santa Barbara, U.S.A.. Author(s): V. Gupta, B. Hwang, N. Doshi, S. Mitragotri. VIEW ABSTRACT

560  Particle Engineering of Acetaminophen Via Spray Drying From Hydroalcoholic Solutions: Improvement In Dissolution Rate. Presenter: Hadi Afrasiabi Garekani, Pharmaceutical research Centre and School of Pharmacy, Mashhad University of Medical Sciences, IRAN. Author(s): H. Afrasiabi. Garekani, F. Sadeghi, M. Khattab. VIEW ABSTRACT

562  Particle formation process of nano-aggregated microparticles. Presenter: Olaf Bork, University of Otago, NEW ZEALAND. Author(s): O. Bork, N. Volpe, I. G. Tucker. VIEW ABSTRACT

564  PlasACRYL HTP20: A New High Performance Easy-To-Use Coating System Additive. Presenter: Firouz Asgarzadeh, Evonik Degussa Corporation, Piscataway, NJ 08854, USA, U.S.A.. Author(s): F. Asgarzadeh, S. Bodinge, A. Guha, S. Chavan. VIEW ABSTRACT

565  Prediction of Release Profiles of Extended Release Indomethacin Capsule Using Multiple Regression Analysis. Presenter: Buket Aksu, Ege University Department of Pharmaceutical Technology, Faculty of Pharmacy, TURKEY. Author(s): B. Aksu, A. Yurdasiper, M. Ege, N. Ustundag. Okur, Y. H. Karasulu. VIEW ABSTRACT

566  Preparation of Sustained Release Microparticles Containing Theophylline and Eudragit RS Using Spray Drying Technique: Comparison Between Organic Solution and Aqueous Dispersion of Polymer. Presenter: Fatemeh Sadeghi, Pharmaceutical research center and School of Pharmacy, Mashhad University of Medical Sciences, IRAN. Author(s): F. Sadeghi, Z. Fatemi. Moghaddam, H. Afrasiabi. Garekani. VIEW ABSTRACT

567  Preparation, Optimization and Characterization of Multiple Unit Microspheres Containing Kollidone SR. Presenter: Marvin Patel, Research Scholar, India. Author(s): M. I. Patel, R. R. Patel. VIEW ABSTRACT

569  Prolonged In Vitro Antifungal Effect of Nystatin-Containing Mucoadhesive Hydrogel Films. Presenter: Balaram Gajra, Assistant Professor, Ramanbhai Patel College of Pharmacy, Charotar University of Science and Technology, Changa-388 421, INDIA. Author(s): B. Gajra, S. S. Pandya. VIEW ABSTRACT

570  Rheological behavior of mucoadhesive liquid crystalline systems for buccal drug delivery. Presenter: Marlus Chorilli, State University of São Paulo, BRAZIL. Author(s): M. Chorilli, G. Calixto, M. Garcia. VIEW ABSTRACT

571  Robustness of Intermediate Molecular Weight HPMC Controlled Release Polymers in Biorelevant Dissolution Test. Presenter: Elanor Pinto, Ashland, U.S.A.. Author(s): E. Pinto, Y. Zong, D. Tewari. VIEW ABSTRACT

572  Solid Dispersions Of Carbamazpine With Lutrol® F127 Using Hot Melt Extrusion. Presenter: Michael Repka, Department of Pharmaceutics, School of Pharmacy, The University of Mississippi, University, U.S.A.. Author(s): M. A. Repka, J. Lu, S. P. Shah, S. Majumdar, K. Kolter, N. Langley. VIEW ABSTRACT

573  Solubility Enhancement of Ibuprofen Melt Extruded Solid Dispersions: In silico predictive Tools and in vitro Dissolution Profiles for Polymeric Carriers. Presenter: Firouz Asgarzadeh, Evonik Industries AG, U.S.A.. Author(s): K. Patwardhan, K. Banks, M. Yang, J. Engleman, E. Rambaud, F. Asgarzadeh. VIEW ABSTRACT

574  Solubility Enhancement of Simvastatin with use of Novel Polymeric Solubilizer Soluplus®. Presenter: Vaishali Tawde, BASF India Ltd, INDIA. Author(s): A. A. Chivate, N. K. Mahajan, V. M. Tawde, V. Potnis. VIEW ABSTRACT

576  Study of the Mechanical, Thermal and Rheological Properties of Ethyl Cellulose as a Film Coating Polymer. Presenter: Abrahem Abrahem, University of Bradford, UNITED KINGDOM. Author(s): A. M. Abrahem, I. Grimsey, T. Gough, M. Isreb, M. De. Matas. VIEW ABSTRACT

577  Supported Bilayer on a Nanopatterned Membrane as Model PAMPA Membranes. Presenter: Souryvanh Nirasay, Depmt of Chemistry, UQAM, CANADA. Author(s): S. Nirasay, J. Claverie, I. Marcotte, Y. Mouget, A. Badia, G. Leclair. VIEW ABSTRACT

578  Tabletting Of Coated Multiparticulates: Effect Of Formulation Composition, Process Variables On Drug Release And Tablet Properties. Presenter: Sateesh Kumar Sathigari, Patheon Pharmaceuticals, U.S.A.. Author(s): S. Sathigari, Y. Chachare, A. Gokhale, B. Stagner, R. Kasina, A. Qu. VIEW ABSTRACT

579  Taste Masking of Bitter APIs Through the Intermolecular Interactions Processed by Hot-Melt Extrusion. Presenter: Dennis Douroumis, University of Greenwich, School of Science, UNITED KINGDOM. Author(s): D. Douroumis, M. Maniruzzaman, D. J. Morgan, A. Mendham, J. Pang, M. Bonnefille, A. Aranyos. VIEW ABSTRACT

580  Terpolymer Solubilizer - Modeling and Experiment Comparison. Presenter: Hans-Michael Walter, BASF SE, GERMANY. Author(s): H. Walter, V. Kurkal-Siebert, F. Becker, S. Fischer. VIEW ABSTRACT

581  The Influence of Level and Location of NaCl on Performance of Push-Pull Osmotic Pump Tablets of a Practically Water Insoluble Model Drug. Presenter: Ali Rajabi-Siahboomi, Colorcon, U.S.A.. Author(s): S. Missaghi, P. Patel, T. P. Farrell, A. R. Rajabi-Siahboomi. VIEW ABSTRACT

582  The method of fine dissolution control of tablets by direct compression in different test media using a novel pregelatinized starch, SwelstarTM MX-1. Presenter: Yurika Tanaka, Asahi Kasei Chemicals Corporation, JAPAN. Author(s): Y. Tanaka, S. Kaneyama, N. Yoshida, K. Obae. VIEW ABSTRACT

583  The Utility of Wet Granulation to Produce Compritol 888 ATO Matrix Tablets for the Sustained Release of Diclofenac Sodium. Presenter: Shabbir Mostafa, Gattefossé, UNITED KINGDOM. Author(s): L. Pulcini, M. Roberts, S. Mostafa, Y. Cuppok. VIEW ABSTRACT

584  Thermal and Rheological Properties of Povidone and Copovidone Polymers for Hot Melt Extrusion Application. Presenter: Mohammed Rahman, Ashland Specialty Ingredients, U.S.A.. Author(s): M. A. Rahman, J. D. Lester, S. Ozkan, V. Bi, T. Durig. VIEW ABSTRACT

585  Transepithelial Transport in Calu-3 Cells Grown Under LCC and AIC Conditions: Impact of Mucus on Drug Permeability. Presenter: Anette Müllertz, Bioneer:FARMA, Faculty of Health Sciences, University of Copenhagen, DENMARK. Author(s): L. Saaby, A. Müllertz. VIEW ABSTRACT

587  Utilization of pH-Metric Titration to Evaluate the Supersaturation Behavior of Weakly Basic Drugs. Presenter: Jon Mole, Sirius Analytical Inc., U.S.A.. Author(s): J. Mole, Y. Hsieh, K. J. Box, G. Ilevbare, L. S. Taylor. VIEW ABSTRACT

707  The excipient, citric acid, does not increase permeability of isolated rat small intestinal epithelia. Presenter: S. Welling, University of Copenhagen, DENMARK. Author(s): S. Welling, J. Jacobsen, D. J. Brayden. VIEW ABSTRACT

Stem Cell and Regenerative Medicines     [RETURN TO TOP]

588  Bio-functionalized pH-sensitive carbonate apatite nanoparticles facilitated intracellular regulation of ES/iPS cells on E-Cad-Fc engineered matrix. Presenter: Sharif Hossain, Tokyo Institute of Technology, 4259 Nagatsuta-cho, Midori-ku, Yokohama-shi, Japan 226-8501., JAPAN. Author(s): S. Hossain. VIEW ABSTRACT

590  Development of a novel drug delivery system based on Protein-Poliacetal Conjugates. Presenter: Gabriela Rodriguez Escalona, Centro de Investigación Principe Felipe, SPAIN. Author(s): G. Rodriguez Escalona. VIEW ABSTRACT

591  Immobilization of Catechol-Functionalized Polymer Nanoparticlesonto Ti Surfaces for Controlled BMP-2 Release. Presenter: Hong Jae Lee, Department of Maxillofacial Biomedical Engineering, School of Dentistry, Kyung Hee University, SOUTH KOREA. Author(s): H. Lee, A. Koo, S. Lee. VIEW ABSTRACT

592  Nano-pillar array for differentiation of human mesenchymal stem cells. Presenter: Sujin Yoon, Kangwon National University, KOREA. Author(s): S. Yoon, H. Kim, J. Choi, Y. Son, E. Jo, Y. Kim, J. Kang, H. Yoo. VIEW ABSTRACT

Theranostics and Cancer Nanotechnologies     [RETURN TO TOP]

595  Alternative sonochemical method for the synthesis of folate-modified human serum albumin (HSA) nanocapsules for targeted drug delivery. Presenter: Alexandra Rollett, Graz University of Technology, AUSTRIA. Author(s): A. Rollett, T. Reiter, P. Nogueira, M. Cardinale, A. Loureiro, A. Gomes, A. Cavaco-Paulo, A. Moreira, A. M. Carmo, G. M. Guebitz. VIEW ABSTRACT

596  Calcium Phosphate Mineralized Self-Assembled Nanocarriers for Enhanced Photodynamic Therapeutic Efficacy. Presenter: Dong Jin Park, Departmemt of Life and Nanopharmaceutical Science, Kyung Hee University, SOUTH KOREA. Author(s): D. Park, K. Min, S. Lee, H. Lee, S. Jeong, S. Lee. VIEW ABSTRACT

597  Cancer Targeted Imaging and Therapy by Stabilized HA Nanoparticles using UV Crosslinking. Presenter: Hong Yeol Yoon, Department of Polymer Science and Engineering, Sungkyunkwan University And Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), SOUTH KOREA. Author(s): H. Yoon, H. Koo, K. Kim, I. Kwon, J. Park. VIEW ABSTRACT

598  Cancer-targeted Theranostic System Based on Low Density Lipoprotein-mimetic Solid Lipid Nanoparticles Incorporating Paclitaxel and Iron Oxide Nanocrystals. Presenter: Jeong Yu Lee, KAIST, SOUTH KOREA. Author(s): J. Lee, K. Bae, M. Oh, Y. Nam. VIEW ABSTRACT

599  Combined Modality Doxorubicin-Based Chemotherapy and Chitosan-Mediated p53 Gene Therapy Enhances Inhibition of Hepatocellular Carcinoma HepG2 Cell Growth. Presenter: Qingxing Xu, University of Illinois at Urbana-Champaign, U.S.A.. Author(s): Q. Xu, C. Wang, D. W. Pack. VIEW ABSTRACT

600  Development of Targeted [64Cu]CuS Nanoparticles for PET/CT Imaging and Photothermal Ablation Therapy. Presenter: Lili Cui, University of Houston, U.S.A.. Author(s): L. Cui, M. Zhou, C. Xiong, C. Li, D. Chow. VIEW ABSTRACT

601  Disulfide-Cross-linked Polymer Micelles as a Carrier of Docetaxel: In Vivo Biodistribution and Antitumor Efficacy. Presenter: Ahn Na Koo, Department of Maxillofacial Biomedical Engineering, School of Dentistry, Kyung Hee University, SOUTH KOREA. Author(s): A. Koo, K. Min, S. Jeong, S. Lee. VIEW ABSTRACT

602  Doxorubicin Delivery to EphB4 Over-expressing Tumor via Cross-linked Polymeric Micelles. Presenter: Jun Zhao, University of Texas MD Anderson Cancer Center, U.S.A.. Author(s): J. Zhao. VIEW ABSTRACT

603  Estradiol-PEG-Appended Multiwalled Carbon Nanotubes for Estrogen Receptor Targeted, Multimodal Delivery of Anticancer Agents. Presenter: Manasmita Das, NIPER, INDIA. Author(s): M. Das, S. Datir, R. P. Singh, S. Jain. VIEW ABSTRACT

604  Facile Preparation of Enzyme-triggered Photodynamic Complex for Tumor Diagnosis and Photodynamic Therapy. Presenter: Wooram Park, The Catholic University of Korea, KOREA. Author(s): W. Park, K. Na. VIEW ABSTRACT

605  Heat Activated Nanobomb; Thermosensitive Polypeptide-Incorporated Liposome. Presenter: Sun Min Park, Samsung Electronics, KOREA. Author(s): S. Park, M. Kim, S. Park, Y. Kim, J. Park, H. Kim. VIEW ABSTRACT

606  Magnetoliposomes prepared by dual asymmetric centrifugation. Presenter: Stephanie Meier, University Medical Center Freiburg, GERMANY. Author(s): S. Meier, G. Pütz, U. Massing, D. von Elverfeldt, S. Barnert, R. Schubert, C. Bode, C. von zur Mühlen. VIEW ABSTRACT

608  Mineralized PEGylated Hyaluronic Acid Nanoparticles as Organic-Inorganic Hybrid Carrier for Cancer Therapy. Presenter: Hwa Seung Han, Sungkyunkwan university, SOUTH KOREA. Author(s): H. Han, R. Heo, S. Gurusamy, J. Park. VIEW ABSTRACT

609  Multicellular Tumor Spheroids for the Evaluation of Nanoparticle Intratumoral Transport. Presenter: Andrew Mikhail, University of Toronto, CANADA. Author(s): A. Mikhail, C. Allen. VIEW ABSTRACT

610  Nanoparticle Mediated Thermoablation in Spinal Column Tumors in a Rat Model of Metastatic Breast Cancer. Presenter: Patricia Zadnik, Johns Hopkins University School of Medicine, U.S.A.. Author(s): P. L. Zadnik, D. M. Sciubba, C. A. Molina, M. Groves, R. Sarabia-Estrada, M. Wabler, J. Mihalic, E. McCarthy, R. Ivkov. VIEW ABSTRACT

613  Non-viral Delivery of siRNA by a Combination of Novel Bioreducible Polymer, FocusedUltrasound, and Microbubbles for Prostate Cancer Treatment. Presenter: Stelios Florinas, CCCD, University of Utah, U.S.A.. Author(s): S. Florinas, S. Kim. VIEW ABSTRACT

614  Polymeric Micelle-based Acidic pH Imaging. Presenter: Han Chang Kang, The Catholic University of Korea, SOUTH KOREA. Author(s): Y. Lee, H. Kang, J. Hu, J. W. Nichols, Y. Bae. VIEW ABSTRACT

615  Protease Imaging System by Using Polyion-complex and Its Applicationto Prostate Cancer. Presenter: Yoshiki Katayama, Department of Applied Chemistry, Kyushu University , JAPAN. Author(s): S. Shiosaki, M. Kuramoto, T. Mori, T. Niidome, Y. Katayama. VIEW ABSTRACT

616  Synthesis and in vitro Properties of Image-Guided and Actively Tumor-Targeted Drug Carriers. Presenter: Brandon Buckway, University of Utah, U.S.A.. Author(s): Y. Wang, B. Buckway, A. Ray, H. Ghandehari. VIEW ABSTRACT

617  Targeted HPMA Copolymers for Image Guided Drug Delivery in Pancreatic Cancer. Presenter: Brandon Buckway, University of Utah, U.S.A.. Author(s): B. Buckway, A. Ray, Y. Wang, H. Ghandehari. VIEW ABSTRACT

Transdermal Drug Delivery     [RETURN TO TOP]

619  A Novel Lipid Carrier for the Delivery of Local Anesthetic Drug. Presenter: Ae-June Wang, Andros Pharmaceuticals Co., Ltd, TAIWAN REP OF CHINA. Author(s): A. Wang, J. Hu, C. Lee, R. Peng, W. Lee. VIEW ABSTRACT

620  A Novel Water-soluble Cyclosporine A Prodrug for Ophthalmic Application. Presenter: Marta Rodriguez-Aller, School of Pharmaceutical Sciences, University of Geneva, University of Lausanne, 1211-Geneva-4, Switzerland, SWITZERLAND. Author(s): M. Rodriguez-Aller, D. Guillarme, S. Rudaz, J. Veuthey, R. Gurny. VIEW ABSTRACT

622  Anti-Wrinkle Treatment by a Dissolving Microneedle Patch. Presenter: Sung-Yun Kwon, TheraJect, Inc., U.S.A.. Author(s): S. Kwon, Y. Jung, E. Kim, M. Kim. VIEW ABSTRACT

623  Development of lipid nanostructured systems containing fluconazole: Evaluation of solubility. Presenter: Fernanda Padilla, Faculty of Pharmaceutical Sciences - UNESP, Araraquara, SP, Brazil, BRAZIL. Author(s): F. Padilla, H. R. Silva, F. K. dos Santos, M. D. Gremião. VIEW ABSTRACT

624  Development of Solid Lipid Nanoparticles for Cutaneous Administration of Trans-resveratrol. Presenter: Roberta Rigon, Faculty of Pharmaceutical Sciences - UNESP, BRAZIL. Author(s): R. B. Rigon, P. Severino, M. A. Santana, M. Chorilli. VIEW ABSTRACT

625  Development of Terbinafine Solid Lipid Nanoparticles for Topical Delivery System. Presenter: Ying-Chen Chen, Taipei Medical University, TAIWAN. Author(s): Y. Chen, H. Ho, C. Hsieh, M. Sheu. VIEW ABSTRACT

626  Effect of 1,8-Cineole on the Percutaneous Absorption of Lomerizine Dihydrochloride. Presenter: Takayuki Furuishi, Department of Physical Chemistry, Hoshi University, JAPAN. Author(s): T. Furuishi, Y. Kato, T. Fukami, T. Suzuki, H. Ueda, K. Tomono. VIEW ABSTRACT

627  Effect of Stretching on Drug Transport Across Human Stratum Corneum. Presenter: Olivia Warren, Harvey Mudd College, U.S.A.. Author(s): O. Warren, K. Runas, M. Hwang, A. Jensen, N. K. Lape. VIEW ABSTRACT

628  Effect of Terpene-Transcutol® Mixtures on the Enhanced Topical Delivery of Naftifine Hydrochloride. Presenter: M. Erdal, Istanbul University Faculty of Pharmacy Department of Pharmaceutical Technology, TURKEY. Author(s): M. Erdal, S. Güngör, Y. Özsoy. VIEW ABSTRACT

629  Efficient Intradermal Delivery of Superoxide Dismutase using a Combination of Liposomes and Iontophoresis for Protection against UV-induced Skin Damage. Presenter: Kentaro Kogure, Kyoto Pharmaceutical University, JAPAN. Author(s): K. Kogure, K. Kigasawa, M. Miyashita, K. Kanamura, S. Hama, H. Harashima, K. Kajimoto. VIEW ABSTRACT

630  Electrically-Controlled Drug Release System to Assist Wound Healing. Presenter: Mark Chase, Crosslink, U.S.A.. Author(s): M. A. Chase, R. Zhu, J. Mbugua, J. Maskrod, J. Jung, T. Nicholson. III, G. Justin, E. Fabrizio, R. Mercado. VIEW ABSTRACT

631  Enhanced topical delivery of skin rejuvenation agents by fractional radiofrequency microporation. Presenter: Ji-Hye Jang, Amorepacific Corporation R&D Center, 314-1, Bora-dong, Giheung-gu, Yongin-si, Gyeonggi-do, SOUTH KOREA. Author(s): J. Park, J. Kim, J. Jang, J. Jung, J. Bae. VIEW ABSTRACT

632  Enhancement of the transport of 5-flurouracil using submicron emulsion. Presenter: Chi-Te Huang, School of Pharmacy, , Kaohsiung Medical University, TAIWAN. Author(s): C. Huang, H. Tsou, Fu, Y. Tsai, P. Wu. VIEW ABSTRACT

633  Finite Element Modeling of Drug Transport Through the Human Stratum Corneum. Presenter: Kyle Chakos, Harvey Mudd College, U.S.A.. Author(s): K. Chakos, J. Wen, J. Chun, N. K. Lape. VIEW ABSTRACT

634  Formulation and characterization of controlled release benzoyl peroxide microsponges. Presenter: Aditya Murhty, BITS-Pilani, Hyderabad Campus, Andhra Pradesh, INDIA. Author(s): A. N. Murhty, B. M. V, P. K. Mandapalli. VIEW ABSTRACT

635  Formulation and in-vitro Evaluation of Terbibafine HCl Loaded Ungual Liposomal Gels. Presenter: Ozgen Ozer, Ege University Faculty of Pharmacy Department of Phamaceutical Technology, TURKEY. Author(s): S. Tuncay, O. Ozer. VIEW ABSTRACT

636  Improving cutaneous delivery of paclitaxel: effect of protein transduction domain, composition and structure of microemulsions. Presenter: Luciana Lopes, Albany College of Pharmacy and Health Sciences, U.S.A.. Author(s): D. Pepe, L. B. Lopes. VIEW ABSTRACT

637  In vitro permeation of donepezil hydrochloride from transdermal films. Presenter: Sevgi Güngör, Department of Pharmaceutical Technology, Faculty of Pharmacy, Istanbul University , TURKEY. Author(s): M. Galipoglu, S. M. Erdal, S. Güngör. VIEW ABSTRACT

638  Influence of PEG on the Metabolism of Prednicarbate in Ex Vivo Human Skin. Presenter: Eleonore Haltner, Across Barriers GmbH, GERMANY. Author(s): E. Haltner, U. Bock. VIEW ABSTRACT

639  In-Vitro Drug Release Testing: Challenges for Drug Eluting Stents (DES). Presenter: Marika Kamberi, Abbott Vascular, Inc., U.S.A.. Author(s): M. Kamberi. VIEW ABSTRACT

640  Liposomal formulations for (+)-catechin topical application. Presenter: Jingyuan Wen, School of Pharmacy, University of Auckland, NEW ZEALAND. Author(s): J. Wen, D. LI, S. Bissessor, H. Lewis, M. Lin, Q. Zhang, Y. Zhu, C. Bunt. VIEW ABSTRACT

641  Microparticle and Microneedle Drug Delivery in Human Skin. Presenter: Tarl Prow, Dermatology Research Centre, The University of Queensland, AUSTRALIA. Author(s): T. W. Prow, A. Ansaldo, Y. Mohammed, A. P. Raphael, H. Soyer. VIEW ABSTRACT

643  Novel PEG-Zein Nanomicelles for Topical Delivery of Retinol. Presenter: Ranjith Kumar Averineni, South Dakota State University, U.S.A.. Author(s): R. Averineni, O. Perumal. VIEW ABSTRACT

644  Optimization of Pilot Scale Manufacturing of a Multi-Source Clobetasol 17-Propionate (CP) Cream. Presenter: Roderick Walker, Rhodes University, REP OF SOUTH AFRICA. Author(s): R. B. Walker, A. F. Fauzee. VIEW ABSTRACT

645  Prevention of the dermal colonization of MRSA by the application of algae microparticles. Presenter: Gerold Lukowski, Institute of Marine Biotechnology, GERMANY. Author(s): G. T. Lukowski, U. Lindequist, S. Mundt. VIEW ABSTRACT

646  Smart micellar systems for targeted cutaneous drug delivery. Presenter: Maria Lapteva, University of Geneva, SWITZERLAND. Author(s): M. Lapteva, K. Mondon, M. Moller, R. Gurny, Y. Kalia. VIEW ABSTRACT

647  Studies on in vitro Release Performance of Hydrophilic Drugs and Lipophilic Drugs in Amphiphilic SIS-based Hot-melt Pressure Sensitive Adhesives. Presenter: Qing Wang, Dalian University Of Technology, Prc Peoples Rep Of China. Author(s): X. Li, Q. Wang. VIEW ABSTRACT

649  Topical Delivery of Curcumin using Ethosomes. Presenter: Rajani Gollapudi, South Dakota State University, U.S.A.. Author(s): R. Gollapudi, R. Averineni, O. Perumal. VIEW ABSTRACT

650  Transdermal Insulin Delivery Enhanced by Photothermal Effect of Gold Nanorods. Presenter: Takuro Niidome, Kyushu University, JAPAN. Author(s): D. Pissuwan, K. Nose, T. Mori, Y. Katayama, T. Niidome. VIEW ABSTRACT

Translational Nanomedicine     [RETURN TO TOP]

651  Apoptotic synergy in colorectal cancer by triple combination with siRNA, paclitaxel and PEGlyated TNF-related apoptosis-inducing ligand (PEG-TRAIL). Presenter: Yeon Lim Jang, Sungkyunkwan University, KOREA. Author(s): J. Jeong, Y. Jang. VIEW ABSTRACT

652  Doxorubicin-incorporated bionanocapsule enhances the radiotherapeutic efficacy without cardiotoxicity. Presenter: Seol Hwa Shin, Institute for Innovative Cancer Research, ASAN Medical Center, KOREA. Author(s): S. Shin, J. Jung, H. Chung, J. Choi, J. Park, H. Park, S. Jeong, S. Kuroda, E. Choi. VIEW ABSTRACT

653  Early translation study on LIPOMER of Doxycycline HCL – Scaleup & Optimization. Presenter: Padma Devarajan, Institute of Chemical Technology, INDIA. Author(s): V. M. Joshi, A. Samad, P. V. Devarajan. VIEW ABSTRACT

654  In vivo Tissue Accumulation and Release of Platinum after local application of a novel Chitosan Hybrid-Gel targeting female reproductive organs. Presenter: Margit Janat-Amsbury, University of Utah, U.S.A.. Author(s): S. Cho, Y. Sun, M. K. Dodson, D. K. Gaffney, C. Peterson, M. M. Janat-Amsbury. VIEW ABSTRACT

655  Kinetic Targeting of pegylated liposomal Doxorubicin: Plasmapheresis reduces Toxicity of Anticancer Chemotherapy (CARL-Trial). Presenter: Gerhard Putz, University Freiburg Medical Center, GERMANY. Author(s): O. Schmah, J. Eckes, J. W. Siebers, U. Groh, S. Zschiedrich, B. Rautenberg, A. Hasenburg, M. J. Hug, K. Winkler, G. Putz. VIEW ABSTRACT

656  Low Cost Biodegradable Hepatic Targeting Nanocarriers of Doxorubicin with Improved Toxicity. Presenter: Mitesh Patel, Institute of Chemical Technology, INDIA. Author(s): M. D. Patel, D. M. Benival, S. A. Guhagarkar, V. C. Malshe, P. V. Devarajan. VIEW ABSTRACT

657  Nanostructured Microparticles that Mimic the Food Effect for Enhancing Oral Drug Absorption. Presenter: Angel Tan, Ian Wark Research Institute, University of South Australia, AUSTRALIA. Author(s): A. Tan, T. Nguyen, B. J. Boyd, C. A. Prestidge. VIEW ABSTRACT

658  PLGA Nanoparticle Property-Biodistribution Relationships and In Vivo Degradation. Presenter: Joshua Reineke, Wayne State University, U.S.A.. Author(s): M. Li, A. Mohammad, J. Reineke. VIEW ABSTRACT

Consumer and Industrial Applications of Nanoparticle Technology     [RETURN TO TOP]

659  Analysis ofDrug-Excipient Miscibility and Its Impact on Particle Formation via Spray-Drying. Presenter: Kohsaku Kawakami, NIMS, JAPAN. Author(s): K. Kawakami, Y. Hasegawa, K. Deguchi, S. Ohki, T. Shimizu, Y. Yoshihashi, E. Yonemochi, K. Terada. VIEW ABSTRACT

660  Comparative Studies on Nicergoline Amorphous and Crystalline nanoparticles. Presenter: Rainer Muller, Freie Universität Berlin, Department of Pharmacy, Pharmaceutical Technology, Biopharmaceutics & NutriCosmetics, GERMANY. Author(s): R. H. Muller, V. Martena, R. S. Sahoo, P. DiMartino. VIEW ABSTRACT

661  Lutein nanosuspension with improved skin penetration in human. Presenter: Rainer Müller, Freie Universität Berlin, Institute of Pharmacy, Department of Pharmaceutics, Biopharmaceutics & NutriCosmetics, Kelchstr. 31, 12169 Berlin, GERMANY. Author(s): M. Mishra, R. Shegokar, R. H. Müller, K. Mitri, S. Gohla. VIEW ABSTRACT

662  Zeta potential measurements of high concentrated fish oil nanoemulsions. Presenter: Rainer Müller, Free University of Berlin, Kelchstr. 31, 12169 Berlin, Germany, GERMANY. Author(s): D. Harden, R. Chen, R. H. Müller, C. M. Keck. VIEW ABSTRACT

Hydrogel Delivery Systems in Consumer Products     [RETURN TO TOP]

663  Effect of Probe Loading on Diffusive Behavior of Proteinsin Polyacrylamide Gels. Presenter: Sidhartha Jena, National Institute of Technology, INDIA. Author(s): S. S. Jena, S. Khandai, R. A. Siegel. VIEW ABSTRACT

664  In Vitro Characterization Studies of Bioadhesive Ketoprofen Gels for Buccal Administration. Presenter: Mine Özyazici, Ege University Faculty of Pharmacy Department of Pharmaceutical Technology, TURKEY. Author(s): S. Rençber, S. Y. Karavana, M. Özyazici. VIEW ABSTRACT

Nutraceuticals and Functional Foods     [RETURN TO TOP]

665  Determination for Moisture Permeation in Film Coating. Presenter: Brian Cheng, Sensient Technologies Inc, U.S.A. Author(s): B. K. Cheng, B. Schad, E. Van. Ness, T. Riley. VIEW ABSTRACT

666  Effects of Gastrointestinal pH Conditions on the Stability of the beta-lactoglobulin/Vitamin D3 Complex and on the Solubility of Vitamin D3. Presenter: Fatoumata Diarrassouba, Universite Laval, CANADA. Author(s): F. Diarrassouba, G. Garrait, G. E. Remondetto, E. Beyssac. VIEW ABSTRACT

667  Influence of folic acid/protein nanocomplexes on the photodegradation of folic acid. Presenter: Li Liang, State Key Lab of Food Science and Technology, School of Food Science and Technology, Jiangnan University, PRC PEOPLES REP OF CHINA. Author(s): L. Liang, M. Subirade. VIEW ABSTRACT

668  QbD Approach for Moisture Barrier Film Coating Development. Presenter: Brian Cheng, Sensient Technologies Inc, U.S.A. Author(s): B. Cheng, B. Schad, E. Van. Ness, T. Riley. VIEW ABSTRACT

Protein and Vaccine Delivery     [RETURN TO TOP]

669  A Biomimetic approach to Active Self-healing Microencapsulation of Proteins in PLGA. Presenter: Ronak Shah, University of Michigan,Deptartment of Pharmaceutical Sciences, U.S.A. Author(s): R. B. Shah, S. P. Schwendeman. VIEW ABSTRACT

670  Activation of splenic marginal zone B cell by PEGylated liposome with lower dose: triggering transport of antigen-containing second dose PEGylated liposome from marginal zone to follicle. Presenter: Taro Shimizu, Department of Pharmacokinetics and Biopharmaceutics, Institute of Health Biosciences, , JAPAN. Author(s): T. Shimizu, T. Ishida, H. Kiwada. VIEW ABSTRACT

671  An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastroresistant microcapsules. Presenter: Amaia Esquisabel, NanoBioCel Group, Laboratory of Pharmaceutics,School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria, 01006, Spain, SPAIN. Author(s): M. Pastor, A. Esquisabel, G. Año, A. Talavera, J. Pedraz. VIEW ABSTRACT

672  An atomic force microscopy based method for biopharmaceutical stability determination. Presenter: Oliver Croad, The University of Nottingham & Molecular Profiles, UNITED KINGDOM. Author(s): O. W. Croad, D. J. Scott, C. J. Roberts, S. Rigby-Singleton, P. M. Williams, S. Allen. VIEW ABSTRACT

673  Antiresorptive Drug Delivery Strategy using Single Chain Fraction Variable as an Osteoclast Targeting Platform. Presenter: Madhuri Newa, University of Alberta, Edmonton, Alberta, CANADA. Author(s): M. Newa, M. Lam, K. H. Bhandari, B. Xu, M. Suresh, M. R. Doschak. VIEW ABSTRACT

674  Aquasomes as a Carrier System for Proteins and Peptides. Presenter: Fadi Abdulrazzaq, Aston University, UNITED KINGDOM. Author(s): F. A. Abdulrazzaq, D. Lowry, Y. Perrie. VIEW ABSTRACT

675  Combined, Sustained, and Bioactive VEGF and HGF Delivery From Low Viscosity Poly(5-ethylene ketal e-caprolactone-co-D,L-lactide). Presenter: Brian Amsden, Queen's University, CANADA. Author(s): O. I. Babasola, B. G. Amsden. VIEW ABSTRACT

676  Comparing liposome manufacturing techniques for the delivery of sub-unit antigens. Presenter: Alexander Wilkinson, Aston University, UNITED KINGDOM. Author(s): A. Wilkinson, R. Kaur, D. Christensen, P. Andersen, A. Mohammed, Y. Perrie. VIEW ABSTRACT

677  Controlled Release of Proteins through Releasable PEGylation. Presenter: Hong Zhao, Enzon Pharmaceuticals, Inc., U.S.A. Author(s): H. Zhao, C. Conover, C. Longley, S. Liu. VIEW ABSTRACT

678  Demonstrating protein integrity within controlled release vaccine particles. Presenter: Barry Moore, XstalBio Ltd, UNITED KINGDOM. Author(s): B. D. Moore, J. Partridge, G. Scott. VIEW ABSTRACT

679  Designing Hydrogel-based Scaffolds for Carrying and Retaining Encapsulated Therapeutic Cells. Presenter: Rosa María Hernández, NanoBioCel Group, Laboratory of Pharmaceutics, School of Pharmacy, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Álava, 01006, Spain., SPAIN. Author(s): A. Acarregui, A. Murua, F. Blanco, G. Orive, J. Pedráz, R. Hernández. VIEW ABSTRACT

680  Development of Albumin-coated Nanoparticle Carrier Systems for Human Growth Hormone. Presenter: Snehal Atwe, University Of The Sciences, U.S.A. Author(s): S. U. Atwe, P. K. Gupta. VIEW ABSTRACT

681  Development of oral insulin nanoparticulate drug delivery system based on aromatic derivatives of chitosan. Presenter: Morteza Rafiee-Tehrani, Department of Pharmaceutics, Faculty of Pharmacy, Tehran University of Medical sciences, IRAN. Author(s): M. Rafiee-Tehrani, R. Mahjub, F. A. Dorkoosh, M. Amini, M. Khoshayand. VIEW ABSTRACT

682  Evaluation of Bone-Targeting Salmon Calcitonin Analogues in Rats Developing Osteoporosis and Adjuvant Arthritis. Presenter: Michael Doschak, University of Alberta, Edmonton, Alberta, CANADA. Author(s): K. H. Bhandari, W. Asghar, M. Newa, F. Jamali, M. R. Doschak. VIEW ABSTRACT

683  Evaluation of Poloxamer 407 and CpG Oligonucleotide as Adjuvants for a Pulmonary Vaccine against Tuberculosis. Presenter: Julie Todoroff, Université Catholique de Louvain, BELGIUM. Author(s): J. Todoroff, B. Ucakar, M. Inglese, S. Vandermarliere, J. Renauld, C. Fillee, K. Huygen, R. Vanbever. VIEW ABSTRACT

684  Folate Coupled Engineered Polymeric Nanoparticles as a Rationally Designed Carrier for Oral Delivery of Insulin. Presenter: Sanyog Jain, National Institute of Pharmaceutical Education and Research (NIPER), INDIA. Author(s): S. Jain, V. V. Rathi, A. K. Jain, M. Das. VIEW ABSTRACT

686  Micro/Nano particulate formulation of a novel polymer based vaccine adjuvant to stimulate cellular and humoral immune system. Presenter: Sunny Kumar, South Dakota State University, U.S.A. Author(s): S. Kumar, H. Tummala. VIEW ABSTRACT

687  Misoprostol Inhibits In Vitro Intestinal Permeation Enhancing Effects of the Medium Chain Fatty Acid, Sodium Caprate (C10). Presenter: Edwin Walsh, University College Dublin, IRELAND. Author(s): E. G. Walsh, S. Maher, D. J. Brayden. VIEW ABSTRACT

688  Nanoscaled buffering zone of charged (PLGA)n-b-bPEI micelles in acidic microclimate for potential protein delivery application. Presenter: Han Chang Kang, The Catholic University of Korea, SOUTH KOREA. Author(s): H. Kang, J. Lee, Y. Bae. VIEW ABSTRACT

690  On/off Control of Enzyme Activity by Domain-specific Oligosaccharide Modification. Presenter: Young Kwon, Nova Southeastern University, U.S.A. Author(s): Y. M. Kwon, S. Absar, S. Choi, V. C. Yang. VIEW ABSTRACT

691  PEGylated TNF-related apoptosis-inducing ligand (TRAIL) suppresses joint inflammation and damage in mouse models of rheumatoid arthritis. Presenter: Kang Choon Lee, College of Pharmacy, SungKyunKwan Univ., SOUTH KOREA. Author(s): K. Lee, T. Kim, H. Jiang. VIEW ABSTRACT

693  Preparation and characterization of insulin nanoparticles withchitosan and Arabic gum using ionic gelation method. Presenter: Assal M.M.Sadeghi, Hakim Pharmaceutical Co., Tehran. Iran, IRAN. Author(s): A. M.M.Sadeghi, M. Avadi, M. Rafiee-Tehrani. VIEW ABSTRACT

694  Protective effects of cell transduction and retention-enhancing metallothionein fusion proteins against hyperglycemia and hypoxia in H9c2 cardiomyocytes. Presenter: Kwang Suk Lim, Hanyang University, SOUTH KOREA. Author(s): K. Lim, J. Kim, Y. Kim. VIEW ABSTRACT

695  Safe and Effective Sublingual Delivery System of Recombinant Human Insulin as an Alternative to the Injection. Presenter: Nilam Patil, Institute of Chemical Technology, INDIA. Author(s): N. H. Patil, P. V. Devarajan. VIEW ABSTRACT

696  Self-Assembled Nanogel Based on Hyaluronic Acid-Green Tea Catechin conjugates for Intracellular Protein Delivery. Presenter: Kun Liang, Institute of Bioengineering and Nanotechnology, SINGAPORE. Author(s): K. Liang, F. Lee, J. Lim, J. Chung, M. Kurisawa. VIEW ABSTRACT

697  Self-Encapsulating PLGA Microspheres for Targeting and Delivery of Vaccine Antigens to APCs. Presenter: Brittany Bailey, University of Michigan, U.S.A. Author(s): B. A. Bailey, K. H. Desai, S. P. Schwendeman. VIEW ABSTRACT

701  Targeted Drug Delivery to the Suprachoroidal Space Using a Microneedle. Presenter: Mark Prausnitz, Georgia Institute of Technology, U.S.A. Author(s): M. R. Prausnitz, S. R. Patel, D. E. Berezovsky, B. E. McCarey, V. Zarnitsyn, H. F. Edelhauser. VIEW ABSTRACT

702  The role of the stabilising component cholesterol in eliciting a liposome or antigen depot-effect in DDA:TDB adjuvant delivery system. Presenter: Randip Kaur, Aston University, United Kingdom. Author(s): R. Kaur, M. Henriksen-Lacey, D. Christensen, Y. Perrie. VIEW ABSTRACT

703  Thermo-Sensitive Polyelectrolyte Nanoparticles For Protein Delivery. Presenter: Young-seok Jung, The Catholic University of Korea, SOUTH KOREA. Author(s): Y. Jung, K. Na. VIEW ABSTRACT

704  Understanding Surfactant Interactions When Producing Niosomes by Analytical Techniques such as Differential Scanning Calorimetry (DSC) and Langmuir Monolayer studies. Presenter: Jitinder Wilkhu, Aston University, UNITED KINGDOM. Author(s): J. S. Wilkhu, D. E. Anderson, Y. Perrie. VIEW ABSTRACT

© Copyright Controlled Release Society  | Contact Us - Report a Bad Link